{
    "name": "cuad_irrevocable_or_perpetual_license",
    "description": "",
    "keywords": [
        "legalbench",
        "cuad_irrevocable_or_perpetual_license"
    ],
    "categories": [
        ""
    ],
    "examples": [
        {
            "input": "Subject to the terms and conditions of this Agreement, Parent hereby grants to each individual member of the SpinCo Group, on behalf of itself and the other members of the Parent Group, and shall cause the other members of the Parent Group to grant to each individual member of the SpinCo Group, a non-exclusive, worldwide, perpetual, irrevocable, fully paid-up, royalty-free right and license, solely for use in the SpinCo Field, to (i)<omitted>use, reproduce, distribute, display, perform, make improvements and exploit Intellectual Property owned or controlled by Parent or a member of the Parent Group and currently used in the SpinCo Business, and (ii) make, have made, use, sell, offer to sell and import any goods and services incorporating, embodying or utilizing such Intellectual Property currently used in the SpinCo Business.",
            "target": "Yes",
            "document_name": "INGEVITYCORP_05_16_2016-EX-10.5-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 0
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Allscripts and its Affiliates a non-exclusive, royalty- free, irrevocable [***] non-transferable (except in accordance with Section 28.4), sublicensable (through multiple levels of sublicensees), fully paid- up right and license under all of the Company's Intellectual Property to use the Company's brands, trademarks, product and service names, logos and slogans (the \"Company Marks\"), throughout the Territory, solely in connection with the marketing, selling, or provision of the Installed Software and the Subscription Software Services and Merchant Processing Services permitted hereunder or to otherwise fulfill the terms of this Agreement. [***].",
            "target": "Yes",
            "document_name": "PHREESIA,INC_05_28_2019-EX-10.18-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 1
        },
        {
            "input": "MS hereby grants (subject to any existing third party contractual obligations) to MSCI a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MSCI to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MS Licensed Materials.",
            "target": "Yes",
            "document_name": "MSCIINC_02_28_2008-EX-10.10-.PDF",
            "index": 2
        },
        {
            "input": "SpinCo, for itself and as representative of all other members of the SpinCo Group, hereby grants to RemainCo (x) a perpetual, irrevocable, exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the SpinCo Know- How currently or previously used in connection with the RemainCo Business or otherwise in the possession of RemainCo or any member of the RemainCo Group as of Distribution Date (the \"Licensed SpinCo Know-How\"), for the continued operation of the RemainCo Business and any future extensions of the RemainCo Business in the RemainCo Core Field and (y) a perpetual, irrevocable, non-exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Licensed SpinCo Know-How for the continued operation of the RemainCo Business and any future extensions of the RemainCo Business in any field other than the RemainCo Core Field or the SpinCo Core Field; provided, however, the foregoing licenses shall not extend to (i) SpinCo Know-How<omitted>licensed by SpinCo or any other member of the SpinCo Group if and to the extent the licensing of same to RemainCo would constitute a breach of an agreement with any Third Party executed prior to the Effective Date or result in any expense to SpinCo or any member of the SpinCo Group for payments to such Third Party or (ii) any intellectual property not owned by one or more members of the SpinCo Group, or as to which no member of the SpinCo Group has the right to grant sublicenses, as of the Effective Date.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 3
        },
        {
            "input": "FMI hereby grants to Roche a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable license to any intellectual property arising from the Immunotherapy Testing Platform Program Controlled by FMI for internal research purposes and to the extent necessary for Roche to research, develop, make, have made, use, offer for sale, sell, import and commercialize Roche products other than diagnostic products.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 4
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, Nuance hereby grants to SpinCo and the members of the SpinCo Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 3.01(g)) license to continue to use any Nuance IP (other than Nuance Patents, Nuance Technology Assets, Nuance Trademarks and Nuance Data), in each case solely as and to the extent that it is used by the SpinCo Group in connection with products and services of the SpinCo Business within the SpinCo Field of Use, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 5
        },
        {
            "input": "Without limiting the foregoing, Equifax hereby grants, and will cause the other members of the Equifax Group to grant, to Certegy a fully paid, non- exclusive, perpetual, worldwide, transferable license to use, modify, improve, create Derivative Works from, and sublicense, the Utility Software Programs (in both object and source code format) identified on Exhibit L as being owned by Equifax or a member of the Equifax Group for any and all fields of use and to any and all Persons.",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 6
        },
        {
            "input": "To the extent necessary to effect the foregoing in a country other than the United States, each Party grants to the other Party a nonexclusive, irrevocable, perpetual, fully-paid, worldwide license, with the right to grant sublicenses, under the granting Party's interest in Joint Program Technology, for any and all purposes, provided that RevMed's interest therein shall be subject to the other terms and conditions of this Agreement, including the exclusive licenses granted herein (during the Term) and all payment obligations.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 7
        },
        {
            "input": "To the extent that Contractor incorporates any of Contractor's Information into the Works, Contractor hereby grants to Company a royalty-free, non- exclusive perpetual license (including the right to grant a sublicense) to use, copy, modify, create, derivative version, publicly perform and publicly display such Contractor's Information in connection with Company's business operations.",
            "target": "Yes",
            "document_name": "MERITLIFEINSURANCECO_06_19_2020-EX-10.(XIV)-MASTER SERVICES AGREEMENT.PDF",
            "index": 8
        },
        {
            "input": "Notwithstanding Section 14.1, in the event that Astellas develops, completely independently from any FG Technology and/or any other FG materials, confidential information, intellectual property or other related information provided by or on behalf of FG to Astellas under this Agreement or any other agreement between FG and Astellas relating to the subject matter hereof, any inventions or intellectual property rights related to the Field or the Expanded Field, [ * ], Astellas shall own such intellectual property and hereby grants to FG and its Sublicensees a non-exclusive, royalty-free, irrevocable license to such intellectual property for the FG Territory.",
            "target": "Yes",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 9
        },
        {
            "input": "LMG will maintain, through the Conversion Date or such other date as is specified in Exhibit A, its existing licenses for the Other Third Party Software and provide TAG access to and an irrevocable \"look access only\" right and license to use the Other Third Party Software and applicable Documentation.",
            "target": "Yes",
            "document_name": "REGANHOLDINGCORP_03_31_2008-EX-10-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 10
        },
        {
            "input": "Accordingly, (i) with respect to RemainCo's right and interest in and to the Shared Library Materials, RemainCo, for itself and as representative of all other members of the RemainCo Group, hereby grants to SpinCo (x) a perpetual (subject to Section 4.4), irrevocable, exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Shared Library Materials, including all Know-How and Copyrights embodied therein, for any purpose in the SpinCo Core Field and (y) a perpetual (subject to Section 4.4), irrevocable, non-exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Shared Library Materials, including all Know-How and Copyrights embodied therein, for any purpose in any field other than the RemainCo Core Field or the SpinCo Core Field and (ii) with respect to SpinCo's right and interest in and to the Shared Library Materials, SpinCo, for itself and as representative of all other members of the SpinCo Group, hereby grants to RemainCo (x) a perpetual (subject to Section 4.4), irrevocable, exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Shared Library Materials, including all Know-How and Copyrights embodied therein, for any purpose in the RemainCo Core Field and (y) a perpetual (subject to Section 4.4), irrevocable, non- exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Shared Library Materials, including all Know-How and Copyrights embodied therein, for any purpose in any field other than the SpinCo Core Field or the RemainCo Core Field.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 11
        },
        {
            "input": "Effective after the Immunotherapy Exclusivity Period, Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable to Affiliates, license to any intellectual property arising from the Immunotherapy Testing Platform Development Program Controlled by Roche (excluding Roche Immunotherapy Sample Results) to the extent necessary<omitted>for FMI to develop, make, have made, use, offer for sale, sell, import and commercialize the Immuno-Biomarker Discovery Platform, Signature Identification services, Clinical Study assays, CDx assays, or any other FMI testing or services (including that are part of the Genomic Analysis Platform).",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 12
        },
        {
            "input": "For greater certainty, \"New Technology\" shall exclude any (x) modification to Philips pre-existing Intellectual Property Rights (which, shall exclude any Intellectual Property Rights forming part of the \"Purchased Assets\" under the Purchase Agreement) and (y) developments developed not for the Products (collectively, \"Philips Retained Product IP'), provided that Philips and its Affiliates hereby grant to Customer under any such Intellectual Property Rights, which are applicable or used for the manufacturing of the Product, a non- exclusive, non-transferable (except in accordance with clause 18.4 (Assignment)), irrevocable, world-wide, fully paid-up license, without the right to grant sub-licenses, to make, have made, sell or commercialize in any other way the Product.",
            "target": "Yes",
            "document_name": "PROFOUNDMEDICALCORP_08_29_2019-EX-4.5-SUPPLY AGREEMENT.PDF",
            "index": 13
        },
        {
            "input": "Effective as of the Initial Closing Date, the Purchaser will cause each Acquired Company and each Purchaser Assignee to grant, following each applicable Closing Date, to the Seller Parties, an irrevocable (except as expressly set forth herein), non-sublicenseable (except as expressly set forth herein), perpetual, fully paid-up, royalty-free, worldwide, non-transferable (except as expressly set forth herein), non-exclusive license, under the Transferred IP (other than Trademarks and Patents) that is or has been, on or prior to the Initial Closing Date, (x) used in connection with the Seller Business, (y) used in connection with the development of any product, service, or system in the Seller Business, or (z) incorporated into any product, service, or system in the Seller Business: (i) (A) to use such Transferred IP in the operation of the Seller Business and to practice any methods, processes, and procedures in connection therewith and (B) to make, have made, use, sell, offer for sale, import, and otherwise dispose of products, services, and systems that were designed, developed, manufactured, distributed, offered for sale, sold, resold, supported, otherwise under development, or provided, as of the applicable Closing Date, by the Seller Parties in connection with in the Seller Business and to practice any methods, processes, and procedures in connection therewith, and in each case of clauses (A) and (B), including with respect to all Derivative Works and natural evolutions thereof; (ii) to make, have made, use, sell, offer for sale, import and otherwise dispose of Smart Sensing Network Equipment; and (iii) to make, have made, use, sell, offer for sale, import, and otherwise dispose of Public Safety LTE Smartphone Devices.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 14
        },
        {
            "input": "Adaptimmune Limited hereby grants MD Anderson a perpetual, irrevocable, no-cost, non-exclusive, royalty-free license to any Adaptimmune Invention or Other Invention in which Adaptimmune Limited has an ownership interest for MD Anderson's internal non-commercial research, academic and patient care purposes.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 15
        },
        {
            "input": "In exchange for the Share Consideration, Licensor hereby grants to Licensee a non-exclusive, royalty-free, perpetual and non-perpetual license (subject to the duration for which Licensor has the rights to each Title as specified in Schedule A1-A5 of Schedule A) to: i. license, exhibit, distribute, reproduce, transmit, perform, display, and otherwise exploit and make available each Title within the Territory in any language by VOD (including SVOD, TVOD, AVOD and free VOD) for Internet, TV and mobile platforms (including, but not limited to, OTT streaming services, Sites and Mobile Sites), except that for Titles listed in Schedule A1-A2 of Schedule A, Licensor can only grant Licensee distribution rights to up to six (6) MSOs plus two (2) of China's Internet TV license holders or their OTT Internet- based video partners by VOD (including SVOD, TVOD, AVOD and free VOD).",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20151124_8-K_EX-10.2_9354744_EX-10.2_Content License Agreement.pdf",
            "index": 16
        },
        {
            "input": "Subject to the terms of this Agreement, subject to Manufacturer meeting EMV's requirements for quality, price and lead- time, EMV hereby grants Manufacturer an exclusive, non-transferable, license (without the right to sublicense) under EMV's Proprietary Rights in the Territory, during the term of this Agreement, to use the Specifications solely for the purpose of manufacturing the Products to fulfil Purchase Orders for EMV.",
            "target": "Yes",
            "document_name": "ELECTRAMECCANICA VEHICLES CORP. - Manufacturing Agreement .PDF",
            "index": 17
        },
        {
            "input": "Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to Affiliates, to use the Roche-Owned Advanced Genomic Analysis Results to develop, make, have made, use, offer for sale, sell, import and commercialize FMI's products and services relating to genomic analysis.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 18
        },
        {
            "input": "Pursuant to the Subscription Agreement, CHT shall obtain from each End User the right to and hereby grants, effective upon the execution and delivery of such End User's Subscription Agreement, to Ehave: (i) a royalty-free, non-exclusive, non-transferable, limited right and licence during the term of such Subscription Agreement to use, copy, store and display the End User Data solely for the purpose of enabling Ehave to operate the Ehave Companion Solution for such End User and as may be necessary for the purpose of enabling Ehave to provide support services in accordance with this Agreement; and (ii) a royalty-free, non-exclusive, limited, perpetual right and license to use, copy, store and display End User Data on an aggregated and anonymous basis and so as not to permit the identification of any End User or individual for the sole purpose of improving or developing enhancements to the Ehave Companion Solution , provided that Ehave shall not have any right to use, commercialize or exploit such End User Data in any other manner or for any other purpose.",
            "target": "Yes",
            "document_name": "EhaveInc_20190515_20-F_EX-4.44_11678816_EX-4.44_License Agreement_ Reseller Agreement.pdf",
            "index": 19
        },
        {
            "input": "Client hereby grants to EFS a limited and perpetual right and license to use such photographs and materials for research and forecasting purposes, including, but not limited to, combining the same with reports and analytics concerning the performance of the Websites, providing information to strategic partners to better define consumer purchasing habits, and for trend forecasting and planning purposes.",
            "target": "Yes",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 20
        },
        {
            "input": "Customer grants to IBM: 1. an irrevocable, nonexclusive, worldwide, paid-up license to use, execute, reproduce, display, perform, distribute (internally and externally) copies of, and prepare derivative works based on Type I Materials; and 2. the right to authorize others to do any of the same.",
            "target": "Yes",
            "document_name": "BLUEFLYINC_03_27_2002-EX-10.27-e-business Hosting Agreement.PDF",
            "index": 21
        },
        {
            "input": "Following the expiration of the Royalty Term with respect to the Licensed Product, the licenses granted under Section 2.1 with respect to such Licensed Product in the Field and the Territory shall be non-exclusive, perpetual, irrevocable, fully-paid and royalty-free.",
            "target": "Yes",
            "document_name": "CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement.pdf",
            "index": 22
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Arizona hereby grants to the Company a perpetual, non- exclusive, royalty-free license in, to and under the Arizona Licensed Copyrights for use in the Company Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 23
        },
        {
            "input": "Subject to the terms and ----------------------------------- conditions of this Agreement, Entrust, to the extent of its legal right to do so, hereby grants to Nortel, under the Entrust Patents, an irrevocable, non- transferable, non-assignable, indivisible, non-exclusive, royalty-free, worldwide license for Licensed Products and Licensed Services.",
            "target": "Yes",
            "document_name": "ENTRUSTINC_07_24_1998-EX-10.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 24
        },
        {
            "input": "Subject to the terms and conditions set forth herein, World Book hereby grants to HSWI, a perpetual, irrevocable limited license to use, copy, store, archive, distribute, transmit, modify (subject to Section 2.1(iv)), and Display the Content, Images and Affinities in whole or",
            "target": "Yes",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 25
        },
        {
            "input": "To the extent any Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay, Life Technologies hereby grants to Biocept, during the Term of this Agreement, and, except in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach, after expiration or termination of this Agreement, a non-exclusive, worldwide, royalty-free, fully-paid license, including the right to sublicense, under Life Technologies' Intellectual Property Rights in such Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.",
            "target": "Yes",
            "document_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 26
        },
        {
            "input": "Accordingly, (i) with respect to RemainCo's right and interest in and to the Foundational Software, RemainCo, for itself and as representative of all other members of the RemainCo Group, hereby grants to SpinCo (x) a perpetual, irrevocable, exclusive, royalty-free, worldwide right and license to use the Foundational Software, including any Intellectual Property embodied therein, for the continued operation of the SpinCo Business and any future extensions of the SpinCo Business in the SpinCo Core Field and (y) a perpetual, irrevocable, non-exclusive, royalty-free, worldwide right and license to use the Foundational Software, including any Intellectual Property embodied therein, for the continued operation of the SpinCo Business and any future extensions of the SpinCo Business in any field other than the SpinCo Core Field or the RemainCo Core Field; and (ii) with respect to SpinCo's right and interest in and to the Foundational Software, SpinCo, for itself and as representative of all other members<omitted>of the SpinCo Group, hereby grants to RemainCo (x) a perpetual, irrevocable, exclusive, royalty-free, worldwide right and license to use the Foundational Software, including any Intellectual Property embodied therein, for the continued operation of the RemainCo Business and any future extensions of the RemainCo Business in the RemainCo Core Field and (y) a perpetual, irrevocable, non-exclusive, royalty-free, worldwide right and license to use the Foundational Software, including any Intellectual Property embodied therein, for the continued operation of the RemainCo Business and any future extensions of the RemainCo Business in any field other than the SpinCo Core Field or the RemainCo Core Field. The foregoing licenses includes the right to reproduce, prepare derivative works, distribute, perform and otherwise exploit such Foundational Software and to use the Foundational Software to design, develop, manufacture, have manufactured, sell and support products and services.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 27
        },
        {
            "input": "Garman hereby grants to Sparkling, a perpetual, fully paid, non-exclusive license entitling Sparkling to use and reproduce the Codes deposited with it pursuant to Section (a) to change, update, add to, or substitute the Codes, the Software or any part thereof, limited to Sparkling's needs for the use and improvement of the Software or Sparkling's operations, provided that Sparkling shall only be entitled to utilize such license if Sparkling terminates this Agreement pursuant to Section 17(c) due to Garman's default, or if Garman ceases to support the Software as required pursuant to this Agreement.",
            "target": "Yes",
            "document_name": "SPARKLINGSPRINGWATERHOLDINGSLTD_07_03_2002-EX-10.13-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 28
        },
        {
            "input": "Unless otherwise agreed in an Order, Supplier grants Bank of America a perpetual, worldwide, irrevocable, nonexclusive royalty free license to any Pre-existing IP embedded in the Work Product, which shall permit Bank of America and any transferee or sublicensee of Bank of America, subject to the restrictions in this Agreement, to make, use, import, reproduce, display, distribute, make derivative works and modify such Pre-existing IP as necessary or desirable for the use of the Work Product.",
            "target": "Yes",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 29
        },
        {
            "input": "Subject to the restrictions set out in Section 2.2, ENERGOUS hereby grants to DIALOG a non-exclusive (subject to Section 2.5), irrevocable, worldwide, sub-licensable (solely in accordance with Section 2.4), royalty-bearing license during the Term under all Product IP to:",
            "target": "Yes",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 30
        },
        {
            "input": "LMG grants TAG a worldwide, nonexclusive, irrevocable, perpetual license to load, execute, access, employ, use, store, or display (\"Use\") the object code version of the LMG Tools and Documentation (the \"License\") for the period specified in Exhibit A in accordance with the terms and conditions of this Agreement.",
            "target": "Yes",
            "document_name": "REGANHOLDINGCORP_03_31_2008-EX-10-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 31
        },
        {
            "input": "The Manufacturer grants exclusive rights to the Customer for the term of ten (10) years from the date of the signing of this agreement and for an indefinite period upon the customer fulfilling the minimum annual purchase requirement as listed in Schedule B. of this agreement.",
            "target": "Yes",
            "document_name": "AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement.pdf",
            "index": 32
        },
        {
            "input": "You hereby grant to us (and agree to obtain from your affiliates, owners, employees, and/or contractors), a perpetual, non-exclusive, and worldwide right to use any such ideas, concepts, methods, techniques and products in any businesses that we and/or our affiliates, franchisees and designees operate. We will have the right to use those ideas, concepts, methods, techniques, and/or products without making payment to you. You agree not to use or allow any other person or entity to use any such concept, method, technique or product without obtaining our prior written approval.",
            "target": "Yes",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 33
        },
        {
            "input": "OntoChem hereby grants to Anixa a non-exclusive, fully paid-up, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses through multiple tiers) under any patents which OntoChem or any of its Affiliates own or control during the term of this Agreement, to make, have made, use, sell, offer for sale and import the Lead Scaffold(s) and products that incorporate compounds from the Lead Scaffold(s).",
            "target": "Yes",
            "document_name": "ANIXABIOSCIENCESINC_06_09_2020-EX-10.1-COLLABORATION AGREEMENT.PDF",
            "index": 34
        },
        {
            "input": "Effective as of the Initial Closing Date, the Seller hereby grants (and will cause each other Seller Party to grant following each applicable Closing Date), to the Purchaser Licensees an irrevocable (except as expressly set forth herein), perpetual, non-sublicenseable (except as expressly set forth herein), fully paid-up, royalty-free, worldwide, non-transferable (except as expressly set forth herein), non-exclusive license, under the Licensed Patents: (i) (A) to use the Licensed Patents in the operation of the Business and to practice any methods, processes, and procedures in connection therewith and (B) to make, have made, use, sell, offer for sale, import and otherwise dispose of products, services, and systems that were designed, developed, manufactured, distributed, offered for sale, sold, resold, supported, otherwise under development, or provided, as of the applicable Closing Date, by the Seller Entities in connection with the Business and to practice any methods, processes, and procedures in connection therewith, and in each case of clauses (A) and (B), including with respect to all Derivative Works and natural evolutions thereof; and (ii) to make, have made, use, sell, offer for sale, import, and otherwise dispose of Smart Sensing Network Equipment.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 35
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, SpinCo hereby grants to Nuance and the members of the Nuance Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 4.01(g)) license to install, access, use, reproduce, perform, display, modify (including the right to create improvements and derivative works), further develop, sell, manufacture, distribute and market products and services based on, using or incorporating the SpinCo Shared Technology Assets within the Nuance Field of Use, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 36
        },
        {
            "input": "Certegy hereby grants, and will cause the other members of the Certegy Group to grant, to Equifax a fully paid, non-exclusive, perpetual, worldwide, non-transferable license to use, modify, copy, improve, create Derivative Works and Equifax Enhancements from, and sublicense the Licensed Certegy Materials (excluding the Utility Software Programs) solely for use in the Equifax Business and as that business may evolve and change in the future, subject to the following: (i) Equifax shall not sublicense, or otherwise disclose or distribute, or permit any Person to use, the Licensed Certegy Materials (excluding the Utility Software Programs), except in accordance with Section 4.4(b); (ii) Equifax shall hold the Licensed Certegy Materials (excluding the Utility Software Programs) in strict confidence; will not remove or destroy any proprietary markings of the Certegy Group on or contained in the Licensed Certegy Materials (excluding the Utility Software Programs); and will include the copyright and patent notices of the licensor as specified from time to time by the licensor for the Licensed Certegy Materials (excluding the Utility Software Programs) on and in all copies of the Licensed Certegy Materials (excluding the Utility Software Programs); (iii) Equifax shall not export or re-export the Licensed Certegy Materials (excluding the Utility Software Programs) without the appropriate United States or foreign government license; and (iv) all sublicenses from Equifax to members of the Equifax Group (A) shall contain the rights and restrictions set forth in this Section 4.4(a) with respect to the license granted to Equifax and comply with Sections 4.4(b) through (d) hereof and (B) shall",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 37
        },
        {
            "input": "PPI Improvements shall be owned by PPI and be licensed to EKR hereunder. EKR Improvements shall be owned by EKR and upon termination of this Agreement by PPI pursuant to Section, shall be deemed be licensed to PPI on a worldwide, non-exclusive, irrevocable basis, at a royalty or for such other consideration as may be mutually agreed upon by the parties in writing.",
            "target": "Yes",
            "document_name": "PACIRA PHARMACEUTICALS, INC. - A&R STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT .PDF",
            "index": 38
        },
        {
            "input": "If the Option is exercised before the expiration of the Option Period, the license grants set forth in Articles 3.00 and 3.01 will become exclusive to Investor for a perpetual term, shall not be subject to a licensing fee, the granted licenses in favor of the Investor shall be deemed fully paid-up, and the rights granted to Investor under Articles 3.00 and 3.01 shall include the right to grant sublicenses to Third Parties.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 39
        },
        {
            "input": "Supplier hereby grants to Bank of America a nonexclusive, fully paid, irrevocable, royalty-free, world-wide license to use, modify, copy, produce derivative works from, display, disclose to persons who have entered into a written agreement containing substantially the same confidentiality provisions as in this Agreement for the purpose of maintaining the Software for Bank of America, and otherwise to utilize the Software and the Source Code and other materials necessary to maintain and improve the Software for use by Bank of America, subject always to the limitations In this Agreement on reproduction and use of the Software.",
            "target": "Yes",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 40
        },
        {
            "input": "To the extent that Reseller or any Other Reseller is deemed to be the owner of all or any portion of the TouchStar Software, any Intellectual Property Rights of TouchStar or any Ancillary Software, or any improvements or intellectual property rights related thereto pursuant to applicable law, Reseller (i) hereby assigns exclusively to TouchStar all rights of Reseller in and to such Software and any improvements and intellectual property rights related thereto royalty-free and exclusively and (ii) shall include in any Other Reseller Agreement provision by which any Other Reseller grants to TouchStar an exclusive, perpetual, irrevocable, royalty-free assignment of all deemed rights of such Other Reseller in and to such TouchStar Software, Ancillary Software and Intellectual Property Rights.",
            "target": "Yes",
            "document_name": "WORLDWIDESTRATEGIESINC_11_02_2005-EX-10-RESELLER AGREEMENT.PDF",
            "index": 41
        },
        {
            "input": "Subject to the provisions of this AGREEMENT, and with effect from the date when the party signing last in time appends its signature to this agreement (\"the effective date\"), and enduring in perpetuity unless terminated as provided for elsewhere in this AGREEMENT, SAP AFRICA grants, and TELKOM accepts a non-exclusive, non-transferable licence to USE the SOFTWARE, DOCUMENTATION and other SAP AFRICA PROPRIETARY INFORMATION at the specified DESIGNATED SITE within the TERRITORY.",
            "target": "Yes",
            "document_name": "TELKOMSALTD_01_30_2003-EX-10-LICENCE AND MAINTENANCE AGREEMENT.PDF",
            "index": 42
        },
        {
            "input": "Investor hereby agrees to grant to Company a non-exclusive, irrevocable, royalty-free license under any Investor Improvement and any patent claiming such Investor Improvement, solely for use in rare earth mineral processing and rare earth separation, to make and have made, use, offer to sell, sell and import products made using the Investor Improvements.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 43
        },
        {
            "input": "Unless earlier terminated pursuant to the provisions hereof, the term of this Agreement and the licenses and other grants of rights (and related obligations) under this Agreement shall (i) with respect to the Arizona Licensed Trademarks, be for the Arizona Trademark License Term, (ii) with respect to the Diamond Licensed Trademarks, be for the Diamond Trademark License Term, (iii) with respect to the Phase- Out Marks, be for the term set forth in Section 6.6, and (iv) with respect to Copyrights, Know-How and Patents, be in perpetuity.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 44
        },
        {
            "input": "Company further grants to Investor, during the duration of the Option Period, a worldwide, royalty-free, non-exclusive, irrevocable license (with the right to grant sublicenses to Affiliates) to use the Technical Information to practice the methods described and claimed in the Patents and to make and have made, use, offer to sell, sell and import products made using the methods, and to make Improvements, and to engage in any activity which would give rise to a claim of infringement (direct or indirect or otherwise) of one or more of the Patents in the absence of a license.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 45
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Seller a perpetual, non-exclusive, royalty-free license in, to and under the Company Licensed Patents for use in the Arizona Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 46
        },
        {
            "input": "Subject to Section 3.1, Consultant agrees that if, in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services any pre-existing invention, discovery, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual property right owned by Consultant or in which Consultant has an interest (\"Prior Inventions\"), (i) Consultant will provide the Company with prior written notice and (ii) the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto.",
            "target": "Yes",
            "document_name": "DRIVENDELIVERIES,INC_05_22_2020-EX-10.4-CONSULTING AGREEMENT.PDF",
            "index": 47
        },
        {
            "input": "Following the expiration of the Term pursuant to clause (a) (but not clause (b)) of Section 12.1.1, the grants in Section 5.1.3 shall become non-exclusive, fully-paid, royalty-free and irrevocable.",
            "target": "Yes",
            "document_name": "HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.PDF",
            "index": 48
        },
        {
            "input": "Upon expiration of this Agreement, the licenses granted to Sanofi under Section 3.1 will become fully paid up, royalty free, perpetual and irrevocable.",
            "target": "Yes",
            "document_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_Development Agreement.pdf",
            "index": 49
        },
        {
            "input": "The term of the license for the Content delivered to HSWI as part of the Affinities, and the Affinities themselves, shall be perpetual, Exclusive, and irrevocable.",
            "target": "Yes",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 50
        },
        {
            "input": "Subject to the provisions of this Agreement including the provisions of Article 8, Changepoint hereby grants to Customer and Customer hereby accepts from Changepoint the perpetual, personal, non-transferable and non-exclusive Software Licenses to use the Licensed Software for Customer's internal business purposes.",
            "target": "Yes",
            "document_name": "CHANGEPOINTCORP_03_08_2000-EX-10.6-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 51
        },
        {
            "input": "If FMI is unwilling or unable to develop and commercialize a CDx Assay for a given country in the Territory as specified in the R&D Plan, and on the timeline set forth in the relevant R&D Plan, for any reason other than a breach of this Agreement by Roche, then FMI hereby grants to Roche a non-exclusive, royalty-free, sublicensable, and perpetual license under any intellectual property invented by FMI arising from the CDx Development Program that is necessary for Roche to develop and commercialize a CDx Assay equivalent in such country in the Territory.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 52
        },
        {
            "input": "Licensee hereby grants to Bioeq during the term of this Agreement (and, subject to Section 15.3.4, after termination<omitted>or expiration of this Agreement) a non-exclusive, fully-paid, irrevocable license (including the right to grant sublicenses) under all Intellectual Property Rights and Know-How Controlled by Licensee and embodied within, or claiming or covering the Licensee Improvements, to Develop, Manufacture, sell, import, or otherwise Commercialize Licensed Products outside of the Territory.",
            "target": "Yes",
            "document_name": "CoherusBiosciencesInc_20200227_10-K_EX-10.29_12021376_EX-10.29_Development Agreement.pdf",
            "index": 53
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty- free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in any applications outside of Carbon Capture Applications.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 54
        },
        {
            "input": "Sections 2(a) [License Grant], 2(b) [Sublicensing], 2(c) [Display of Titles], 2(d) [Removal of Titles], 3, and 11 shall survive the expiration or termination of this Agreement: (i) in perpetuity with respect to Titles for which the licenses granted in Section 2(a) [License Grant] are perpetual; and (ii) for the duration of the applicable license term specified in Schedule A with respect to Titles for which the license term specified in Schedule A extends beyond the expiration or termination of this Agreement.",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 55
        },
        {
            "input": "Following expiration of the Royalty Term (as defined in the License Agreement) for any Licensed Product in a given country, the license granted to Vericel under Section 9.1 of this Agreement with respect to such Licensed Product in such country shall automatically become fully paid-up, perpetual, irrevocable and royalty-free.",
            "target": "Yes",
            "document_name": "VERICELCORP_08_06_2019-EX-10.10-SUPPLY AGREEMENT.PDF",
            "index": 56
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)), right and license to practice Program Results solely for Power Applications and Hydrogen Applications.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 57
        },
        {
            "input": "Publishers grant to HealthGate a perpetual, royalty-free licence to use the Specification.",
            "target": "Yes",
            "document_name": "HEALTHGATEDATACORP_11_24_1999-EX-10.1-HOSTING AND MANAGEMENT AGREEMENT (1).pdf",
            "index": 58
        },
        {
            "input": "Achaogen shall be responsible for the prosecution and maintenance of any Patent applications and Patents claiming or covering any Achaogen Inventions, and Microgenics shall be responsible for the prosecution and maintenance of any Patent applications and Patents claiming or covering any Microgenics Inventions; provided, that [***] shall not, without first obtaining [***] prior written consent, file any Patent claiming or covering the [***]; provided, further, that, in the event that any such Patent applications covering or claiming any [***] are filed without first obtaining [***] prior written consent, then [***] hereby grants [***] a perpetual, irrevocable, fully paid-up, royalty-free, worldwide, sublicenseable, non-exclusive license under such Patent applications and any Patents issuing therefrom or related thereto for the purpose of developing, manufacturing, using or commercializing [***].",
            "target": "Yes",
            "document_name": "Microgenics Corporation - Collaborative Development and Commercialization Agreement.PDF",
            "index": 59
        },
        {
            "input": "Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to FMI's Affiliates, under any intellectual property rights arising directly from the Sample Results, or the correlation of the Sample Results to patient data (\"Biomarker IP\") (i) to the extent such Biomarker IP becomes publicly known, for internal research purposes, (ii) to the extent such Biomarker IP becomes publicly known, to develop, make, have made, use, offer for sale, sell, import, and commercialize FMI's Products and Services relating to genomic analysis, and (iii) [\u2026***\u2026].",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 60
        },
        {
            "input": "MD Anderson hereby grants Adaptimmune and Adaptimmune Limited a non-exclusive, worldwide, irrevocable royalty-free license to any Invention in which MD Anderson has an ownership interest, for any purpose.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 61
        },
        {
            "input": "RemainCo, for itself and as representative of all other members of the RemainCo Group, hereby grants to SpinCo (x) a perpetual, irrevocable, exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the RemainCo Know-How currently or previously used in connection with the SpinCo Business or otherwise in the possession of SpinCo or any member of the SpinCo Group as of the Distribution Date (the \"Licensed RemainCo Know-How\"), for the continued operation of the SpinCo Business and any future extensions of the SpinCo Business in the SpinCo Core Field and (y) a perpetual, irrevocable, non-exclusive, royalty-free, worldwide right and license with the right to grant sublicenses (solely as set forth in Section 5.6) to use the Licensed RemainCo Know-How for the continued operation of the SpinCo Business and any future extensions of the SpinCo Business in any field other than the RemainCo Core Field or the SpinCo Core Field; provided, however, the foregoing licenses shall not extend to (i) RemainCo Know-How licensed by RemainCo or any other member of the RemainCo Group if and to the extent the licensing of same to SpinCo would constitute a breach of an agreement with any Third Party executed prior to the Effective Date or result in any expense to RemainCo or any member of the RemainCo Group for payments to such Third Party or (ii) any intellectual property not owned by one or more members of the RemainCo Group, or as to which no member of the RemainCo Group has the right to grant sublicenses, as of the Effective Date.",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 62
        },
        {
            "input": "In the event of a termination of this Agreement, FG shall have an irrevocable, exclusive, license, with the right to grant and authorize sublicenses, to any trademarks used by Astellas in association with the Lead Compounds hereunder to make, use, sell, import and otherwise exploit products within the Field in the Astellas Territory.",
            "target": "Yes",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 63
        },
        {
            "input": "Equifax hereby grants, and will cause the other members of the Equifax Group to grant, to Certegy a fully paid, non-exclusive, perpetual, worldwide, non-transferable license to use, modify, copy, improve, create Derivative Works and Certegy Enhancements from, and sublicense the Licensed Equifax Materials (excluding the Utility Software Programs) solely for use in the Certegy Business and as that business may evolve and change in the future, subject to the following: (i) Certegy shall not sublicense, or otherwise disclose or distribute, or permit any Person to use, the Licensed Equifax Materials (excluding the Utility Software Programs), except in accordance with Section 4.1(b); (ii) Certegy shall hold the Licensed Equifax Materials (excluding the Utility Software Programs) in strict confidence; will not remove or destroy any proprietary markings of the Equifax Group on or contained in the Licensed Equifax Materials (excluding the Utility<omitted>Software Programs); and will include the copyright and patent notices of the licensor as specified from time to time by the licensor for the Licensed Equifax Materials (excluding the Utility Software Programs) on and in all copies of the Licensed Equifax Materials (excluding the Utility Software Programs); (iii) Certegy shall not export or re-export the Licensed Equifax Materials (excluding the Utility Software Programs) without the appropriate United States or foreign government licenses; and (iv) all sublicenses from Certegy to members of the Certegy Group (A) shall contain the rights and restrictions set forth in this Section 4.1(a) with respect to the license granted to Certegy and comply with Sections 4.1(b) through (d) hereof and (B) shall be diligently enforced by Certegy.",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 64
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Seller a perpetual, non- exclusive, royalty-free license in, to and under the Company Licensed Know-How for use in the Arizona Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 65
        },
        {
            "input": "Subject to Section 3.2, a Licensor Party, on behalf of itself and the other members of the Licensor Group, and solely to the extent the Licensor Party or another member of the Licensor Group has the right to do so, hereby grants and agrees to grant to the applicable Licensee Party and the other members of the Licensee Group, subject to the field restriction of Section 3.1.2, a royalty-free, nonexclusive, perpetual, irrevocable, fully paid-up, worldwide right and license, with the right to sublicense as provided in Section 3.1.3, to Exploit Intellectual Property Rights that are owned by the Licensor Party or another member of the Licensor Group immediately following the assignments pursuant to Article II and meet one or more of the following descriptions with respect to the relevant Licensee Party: (a) the Intellectual Property Rights are rights under Licensed Patents or other Intellectual Property Rights that, in each case, as of the Effective Time, are either (A) used in connection with, or necessary for the ongoing conduct of, the current business of the Licensee Party or another member of the Licensee Group, or (B) Contemplated to be Used in the business of the Licensee Party, or another member of the Licensee Group, in the Licensee Group Field; provided, however, that the license granted in this Section 3.1.1(a) does not apply to the Intellectual Property Rights received under or otherwise governed by an Excluded Agreement; and/or (b) the Intellectual Property Rights are embodied in an invention, or proposed invention, that is both (i) described in a Patent or Invention Disclosure held by the Licensor Party or another member of the Licensor Group and (ii) conceived by at least one inventor who, at the time of conception, was employed by a member of the Licensee Group, a non-inclusive list of which inventions and proposed inventions are provided in Schedule 3.1.1(b), provided, however, that the license granted in this Section 3.1.1(b) does not apply to an invention conceived under or otherwise governed by an Excluded Agreement; and/or (c) the Intellectual Property Rights are subject to an assignment to the Licensor Party in Section 2.1.1(b) concerning Performer Foreground-Delivered IPR conceived or created in the course of services concerning which the Licensor Party or another member of the Licensor Group was the Requester and the Licensee Party or another member of the Licensee Group was the Performer; and/or<omitted>(d) the Intellectual Property Rights are Performer Background IPR or Patent rights of the Licensor Party or another member of the Licensor Group and is necessary for the Licensee Party or another member of the Licensee Party to Exploit the Performer Foreground-Delivered IPR in the Licensee Group Field, provided, however, that the license granted in this Section 3.1.1(d) applies only to the extent necessary for the Licensee Party or another member of the Licensee Group to Exploit the Performer Foreground-Delivered IPR in the Licensee Group Field.",
            "target": "Yes",
            "document_name": "OTISWORLDWIDECORP_04_03_2020-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT by and among UNITED TECHNOLOGIES CORPORATION, OTIS WORLDWIDE CORPORATION and CARRIER ~1.PDF",
            "index": 66
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Allscripts a non-exclusive, royalty-free, irrevocable , non-transferable (except in accordance with Section 28.4), sublicensable (through multiple levels of sublicensees), fully paid-up right and license under all of the Company's Intellectual Property to access, use, reproduce, perform, display, transmit, demonstrate, test, operate, port, configure, distribute, and make derivative works of the Documentation, Company Marketing Materials and Allscripts Marketing Materials, in whole or in part, throughout the Territory, for any purpose consistent with Section 8.1, [***].",
            "target": "Yes",
            "document_name": "PHREESIA,INC_05_28_2019-EX-10.18-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 67
        },
        {
            "input": "As of the Closing Date, Equifax and Certegy shall each have the perpetual, fully paid, worldwide right and license to make, use, sell, copy, distribute, import, develop Derivative Works or enhancements of, and publicly perform and display, for any purpose, the entire APPLY software product (to the extent the licensee does not already own the same), in both source and object code format, and the documentation thereof without any obligation (including any obligation to account or pay royalties) or liability to the other owner.",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 68
        },
        {
            "input": "Subject to XENCOR's adherence to the obligations under this Agreement, BII hereby grants XENCOR a worldwide, irrevocable, exclusive, sublicensable and royalty free license to use the Process and all reasonably necessary related BII Confidential Information and Know- How, BII Technology and BII Intellectual Property for the sole purpose of making and having made the Product; provided that such license shall become effective only upon complete payment of the Technology Access Fee, as applicable.",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 69
        },
        {
            "input": "MD Anderson also grants LBIO a non-exclusive, royalty free, perpetual license (with rights to sub-license) under, in and to any and all data generated by MD Anderson in conducting studies of TILs in double refractory melanoma outside of the Collaboration and as of the Effective Date, and LBIO shall have unrestricted rights to use such double refractory melanoma data in governmental and regulatory submissions, including submissions that may become public.",
            "target": "Yes",
            "document_name": "IOVANCEBIOTHERAPEUTICS,INC_08_03_2017-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 70
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, SpinCo hereby grants to Nuance and the members of the Nuance Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 4.01(g)) license under the SpinCo Patents, solely to the extent that claims of the SpinCo Patents cover products or services of the Nuance Business in the Nuance Field of Use, together with natural extensions and evolutions thereof, in each case to make, have made use, sell, offer for sale, import and otherwise exploit such products and services, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 71
        },
        {
            "input": "Hence, as of the Distribution Date, Honeywell hereby grants, and agrees to cause the members of the Honeywell Group to hereby grant, to SpinCo and the members of the SpinCo Group a non-exclusive, royalty-free, fully-paid, perpetual, sublicenseable (solely to Subsidiaries and suppliers for \"have-made\" purposes), worldwide license to use and exercise rights under the Honeywell Shared IP (excluding Trademarks, the Honeywell Content and the subject matter of any other Ancillary Agreement), said license being limited to use of a similar type, scope and extent as used in the SpinCo Business prior to the Distribution Date and the natural growth and development thereof.",
            "target": "Yes",
            "document_name": "GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement.pdf",
            "index": 72
        },
        {
            "input": "Except as the parties may otherwise agree in writing, Converge, to the extent it has the legal right to do so, hereby grants to Vert an irrevocable, perpetual, world-wide, non-exclusive right and license to use, load, store, transmit, execute, copy, market, distribute, in any medium or distribution technology whatsoever, known or unknown, display, perform and sublicense the Converge-Independent Materials and the Third-Party Materials, in both Source Code and Object Code formats, and to make unlimited instantiations thereof, for any and all purposes.",
            "target": "Yes",
            "document_name": "VERTICALNETINC_04_01_2002-EX-10.19-MAINTENANCE AND SUPPORT AGREEMENT.PDF",
            "index": 73
        },
        {
            "input": "FMI hereby grants to Roche (i) an exclusive, royalty-free, sublicensable, worldwide and perpetual license to any intellectual property rights arising from the ctDNA Development Platform Program that are necessary for Roche to develop, make, have made, use, offer for sale, sell, import and commercialize Roche products other than diagnostic products (including the use, formulation, methods of treatment, clinical data or other data, information or results relating to the Roche therapeutic product) solely for use in connection with such activities and such Roche products and (ii) a non-exclusive, royalty-free, worldwide and perpetual license, with the right to grant sublicenses solely to Roche Affiliates, to any intellectual property rights arising from the ctDNA Development Platform Program, for internal research purposes. Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable license to any IP Controlled by Roche and developed under the ctDNA Platform Development Program (excluding Roche Immunotherapy Sample Results) to the extent necessary for FMI to research, develop, make, have made, use, offer for sale, sell, import and commercialize the ctDNA Assays.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 74
        },
        {
            "input": "Individual grants Lifeway together with its affiliates, subsidiaries, parent companies and their representatives and employees have an unlimited, perpetual, non-exclusive, worldwide and, except as set forth in Section 9, royalty-free, right to use, reuse, publish, reproduce, perform, copy, create derivative works, exhibit, broadcast, and display throughout the world the name, image and likeness of Individual in Marketing Materials (as defined below) in connection with marketing, advertising or otherwise promoting the Lifeway products and/or services and for historical reference and display purposes and other internal purposes, including without limitation, internal sales meetings.",
            "target": "Yes",
            "document_name": "LifewayFoodsInc_20160316_10-K_EX-10.24_9489766_EX-10.24_Endorsement Agreement.pdf",
            "index": 75
        },
        {
            "input": "For those countries where a specific license is required for a joint owner of a Joint Invention or Joint Improvement to practice such Joint Invention or Joint Improvement, in such country, each Party hereby grants to the other Party a perpetual, irrevocable, non-exclusive, worldwide, royalty-free, fully paid-up license, transferable and sublicensable, under such Party's right, title and interest in and to such Joint Invention or Joint Improvement to freely exploit such Joint Invention or Joint Improvement in such country, subject to the terms and conditions of this Agreement and the licenses granted hereunder.",
            "target": "Yes",
            "document_name": "CoherusBiosciencesInc_20200227_10-K_EX-10.29_12021376_EX-10.29_Development Agreement.pdf",
            "index": 76
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, SpinCo hereby grants to each individual member of the Parent Group, on behalf of itself and the other members of the SpinCo Group, and shall cause the other members of the SpinCo Group to grant to each individual member of the Parent Group, a non-exclusive, worldwide, perpetual, irrevocable, fully paid-up, royalty-free right and license, for use in the Parent Field, to (i) use, reproduce, distribute, display, perform, make Improvements and exploit the Licensed SpinCo IP, and (ii) make, have made, use, sell, offer to sell and import any goods and services incorporating, embodying or utilizing the Licensed SpinCo IP.",
            "target": "Yes",
            "document_name": "INGEVITYCORP_05_16_2016-EX-10.5-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 77
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Allscripts hereby grants to the Company a non-exclusive, royalty-free, irrevocable [***] non-transferable (except in accordance with Section 28.4), fully paid-up right and license under all of Allscripts' Intellectual Property to use the Allscripts Marks, throughout the Territory, solely in connection with providing the Installed Software and Subscription Software Services to Sublicensed Customers who have signed a Customer Agreement and to otherwise fulfill the terms of this Agreement.",
            "target": "Yes",
            "document_name": "PHREESIA,INC_05_28_2019-EX-10.18-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 78
        },
        {
            "input": "Sections 2(a), 2(b), 2(c), 2(d), 3, and 11 shall survive the expiration or termination of this Agreement: (i) in perpetuity with respect to Titles for which the licenses granted in Section 2(a) are perpetual; and (ii) for the duration of the applicable license term specified in Schedule A with respect to Titles for which the license term specified in Schedule A extends beyond the expiration or termination of this Agreement.",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20151124_8-K_EX-10.2_9354744_EX-10.2_Content License Agreement.pdf",
            "index": 79
        },
        {
            "input": "Consultant agrees that if, in the course of performing the Services, Consultant incorporates into any Invention developed hereunder any invention, improvement, development concept, discovery or other proprietary subject matter owned by Consultant or in which Consultant has an interest (\"Item\"), Consultant will inform Company in writing thereof, and Company is hereby granted and shall have a non-exclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made, modify, reproduce, display, use and sell such Item as part of or in connection with the exploitation of such Invention.",
            "target": "Yes",
            "document_name": "KIROMICBIOPHARMA,INC_05_11_2020-EX-10.23-CONSULTING AGREEMENT.PDF",
            "index": 80
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Commerce One hereby grants to Corio a fee-bearing, perpetual and irrevocable, nonexclusive, nontransferable (except in accordance with Section 14.1 of this Agreement), right and license in the Territory to (i) reproduce the Software in machine executable object code format only for installation on the Corio Servers; (ii) install multiple copies of the Software on Corio's Servers which will be made remotely accessible to Corio's Customers for their subsequent use, (iii) permit limited access to and use of the Software and MarketSite.net Service by Customers through Corio Servers; (iv) sublicense an unlimited number of Customers to access and use the Software and MarketSite.net Service only through the installation on Corio servers; and (v) use Commerce One's tools and utilities, subject to any restrictions placed on the Commerce One by third party software providers, to modify and manage the Software.",
            "target": "Yes",
            "document_name": "CORIOINC_07_20_2000-EX-10.5-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 81
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Arizona hereby grants to the Company a perpetual, non-exclusive, royalty-free license in, to and under the Arizona Licensed Patents for use in the Company Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 82
        },
        {
            "input": "MSCI hereby grants (subject to any existing third party contractual obligations) to MS a non-exclusive, perpetual, irrevocable, world- wide, royalty-free license for MS to use, modify, copy, create derivative works of and sublicense, for any business purpose, the MSCI Licensed Materials.",
            "target": "Yes",
            "document_name": "MSCIINC_02_28_2008-EX-10.10-.PDF",
            "index": 83
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, Nuance hereby grants to SpinCo and the members of the SpinCo Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 3.01(g)) license to install, access, use, reproduce, perform, display, modify (including the right to create improvements and derivative works), further develop, sell, manufacture, distribute and market products and services based on, using or incorporating the Nuance Shared Technology Assets within the SpinCo Field of Use, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 84
        },
        {
            "input": "In the event that termination is elected by Ginkgo based upon an Extended Force Majeure Event with respect to BLI pursuant to Section 13.2.1 (Force Majeure), then, as of the effective date of termination:<omitted>(c) the licenses granted to Ginkgo from BLI in Section 9.1.1 (Scope of Grants) and 9.1.2 (License Grant to Exploit [***]) shall survive and become perpetual, irrevocable and, subject to clause (f) of this Section 13.3.2, royalty-free;",
            "target": "Yes",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 85
        },
        {
            "input": "In the event that termination is the result of Ginkgo exercising the Buy-Down Election (including payment of the Buy-Down Amount), then, as of the effective date of termination:<omitted>(c) the licenses granted to Ginkgo from BLI in Section 9.1.1 (Scope of Grants) and 9.1.2 (License Grant to Exploit [***]) shall survive and become perpetual and irrevocable;",
            "target": "Yes",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 86
        },
        {
            "input": "Notwithstanding any termination of this Agreement, any Approved Content that includes Zynga's Licensed Property may remain in perpetuity in any media in which such Licensed Property was integrated into during the Term (e.g., televised WPT Tournaments or WPT Invitational Tournaments, social media posts, repurposed integrations for \"best of\" television programs) or for historical purposes (e.g., reference on WPT's website that Zynga-sponsored tour events took place as part of the tour).",
            "target": "Yes",
            "document_name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.19_11788293_EX-10.19_Content License Agreement.pdf",
            "index": 87
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Allscripts and its Affiliates a non- exclusive, royalty-free, irrevocable [***] non-transferable (except in accordance with Section 28.4), sublicensable (through multiple levels of sublicensees), fully paid-up right and license under all of the Company's Intellectual Property to, throughout the Territory, access, use, reproduce, perform, display, modify, create derivative works of, transmit, demonstrate, test, operate, port, configure, distribute, and make available the Installed Software and Subscription Software Services",
            "target": "Yes",
            "document_name": "PHREESIA,INC_05_28_2019-EX-10.18-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 88
        },
        {
            "input": "Without limiting the foregoing, Certegy hereby grants, and will cause the other members of the Certegy Group to grant, to Equifax a fully paid, non- exclusive, perpetual, worldwide, transferable license to use, modify, improve, create Derivative Works from, and sublicense, the Utility Software Programs (in both object and source code format) identified on Exhibit L as being owned by Certegy or a member of the Certegy Group for any and all fields of use and to any and all Persons.",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 89
        },
        {
            "input": "If the Client, in its reasonable discretion, consents, the Client is hereby granted an exclusive, worldwide, royalty-free, perpetual, irrevocable license to use, distribute, modify, publish, and otherwise exploit the incorporated items in connection with the work product developed for the Client.",
            "target": "Yes",
            "document_name": "ClickstreamCorp_20200330_1-A_EX1A-6 MAT CTRCT_12089935_EX1A-6 MAT CTRCT_Development Agreement.pdf",
            "index": 90
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, Nuance hereby grants to SpinCo and the members of the SpinCo Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 3.01(g)) license under the Nuance Patents, solely to the extent that claims of the Nuance Patents cover products or services of the SpinCo Business in the SpinCo Field of Use, together with natural extensions and evolutions thereof, in each case to make, have made, use, sell, offer for sale, import and otherwise exploit such products and services, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 91
        },
        {
            "input": "In the event that such assignment would be unlawful, Vyera shall, and hereby does, grant to CytoDyn an exclusive, irrevocable, worldwide, sublicensable (including through multiple tiers), transferrable (without consent) royalty free license to any and all right, title and/or interest that it may have in or to an Invention.",
            "target": "Yes",
            "document_name": "CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement.pdf",
            "index": 92
        },
        {
            "input": "FMI hereby grants to Roche a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to Roche's Affiliates under any FMI Improvements for Roche's internal research purposes and to develop, make, have made, use, offer for sale, sell, import and commercialize Roche's products and services other than diagnostic products and services.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 93
        },
        {
            "input": "The Parties shall negotiate in good faith a royalty-bearing, perpetual, world-wide, non-exclusive license to any New Application Technology in which they acquire rights as set forth in Section 8.2.3 above. Royalties and other terms shall be commercially reasonable and negotiated by the Parties in good faith.",
            "target": "Yes",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 94
        },
        {
            "input": "ETI, on behalf of Entrust, grants to NTL and its ------------ Affiliates (as defined in the Enterprise License) a non-exclusive, fully paid- up, worldwide, perpetual license to use an unlimited number of copies of the Entrust Products subject to the terms and conditions of an agreement to be concluded between NTL and ETI promptly after the Effective Date in substantially the form of the license set forth in Exhibit B (the \"Enterprise License\") save ------------------ as amended to comply with the provisions of this Article III.",
            "target": "Yes",
            "document_name": "ENTRUSTINC_07_24_1998-EX-10.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 95
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub-licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non- transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 2 Technology in Power Applications and Hydrogen Applications.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 96
        },
        {
            "input": "IBM grants Customer an irrevocable, nonexclusive, worldwide, paid-up license to use, execute, reproduce, display, perform, and distribute, within Customer's Enterprise only, copies of Type II Materials.",
            "target": "Yes",
            "document_name": "BLUEFLYINC_03_27_2002-EX-10.27-e-business Hosting Agreement.PDF",
            "index": 97
        },
        {
            "input": "MD Anderson hereby grants LBIO a non-exclusive, royalty free, perpetual license (with rights to sub-license) under, in and to all Background Intellectual Property that is: (a) owned by MD Anderson; (b) consists of and/or comprises the manufacturing protocol utilized by MD Anderson in the conduct of a Study; and (c) reasonably necessary to exploit (including developing, obtaining and maintaining regulatory approval for, manufacturing, or commercializing) any Invention, Study result, or Study article, or any improvement or derivative thereof, strictly limited to the Fields (collectively, the \"Non-Exclusively Licensed MD Anderson Background Intellectual Property\"), to the extent that such Non- Exclusively Licensed MD Anderson Background Intellectual Property does not include Third Party IP (as defined hereinafter).",
            "target": "Yes",
            "document_name": "IOVANCEBIOTHERAPEUTICS,INC_08_03_2017-EX-10.1-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 98
        },
        {
            "input": "Upon the expiration of the Royalty Term, the license granted to Vyera under Section 2.1 of this Agreement shall become non-exclusive, fully-paid, royalty free, perpetual and irrevocable.",
            "target": "Yes",
            "document_name": "CytodynInc_20200109_10-Q_EX-10.5_11941634_EX-10.5_License Agreement.pdf",
            "index": 99
        },
        {
            "input": "Eutectix hereby grants to Liquidmetal a fully-paid up, royalty-free, perpetual, world-wide, non-exclusive license to any New Process Technologies in which Eutectix acquires licensing rights pursuant to Section 8.2 above.",
            "target": "Yes",
            "document_name": "LiquidmetalTechnologiesInc_20200205_8-K_EX-10.1_11968198_EX-10.1_Development Agreement.pdf",
            "index": 100
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, the Company hereby grants to Seller a perpetual, non- exclusive, royalty-free license in, to and under the Company Licensed Copyrights for use in the Arizona Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 101
        },
        {
            "input": "XENCOR hereby grants to BII and BII herewith accepts a non exclusive, worldwide, irrevocable, sublicensable (in several cascades), perpetual, royalty-free/fully paid up license under the XENCOR Intellectual Property to the extent it is generally applicable to the manufacturing of biopharmaceutical products, handling<omitted>of cell lines and/or development of manufacturing processes, to use such XENCOR Intellectual Property in for the manufacture of biopharmaceutical products, handling of cell lines and/or development of manufacturing processes, but excluding any use with respect to the Product (or any modification, derivative or fragment thereof).",
            "target": "Yes",
            "document_name": "XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).PDF",
            "index": 102
        },
        {
            "input": "Notwithstanding the aforesaid, it is agreed that any manufacturing methods applied by Contractor, which are Contractor's Proprietary Information, may be used by NICE itself (including its Affiliates) (but may not be transferred/disclosed to any third party) and by signing this Agreement Contractor hereby grants NICE a personal, non exclusive, non transferable, perpetual license to use such manufacturing methods.",
            "target": "Yes",
            "document_name": "NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.PDF",
            "index": 103
        },
        {
            "input": "Aimmune hereby grants to Xencor an exclusive license under and with respect to Aimmune Patents, and a non-exclusive license under and with respect to Aimmune Know-How, in each case, where such license is an irrevocable, perpetual, royalty-bearing license, with the right to sublicense, to Develop, Manufacture and Commercialize the Product(s), as the Product(s) exist as of the effective date of such termination, or optimized versions thereof that are Products.",
            "target": "Yes",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 104
        },
        {
            "input": "Supplier hereby grants Bank of America a nonexclusive, worldwide, irrevocable, perpetual license to install, use, execute and copy the Software described in each Product License Schedule as necessary to conduct Bank of America business in accordance with the terms and restrictions of this Section and any special terms and restrictions stated on the applicable Product License Schedule.",
            "target": "Yes",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 105
        },
        {
            "input": "In exchange for the Share Consideration, Licensor hereby grants to Licensee a non-exclusive, royalty-free, perpetual and non-perpetual license (subject to the duration and scope, and format limitations for which Licensor has the rights to each Title as specified in Schedule A1-A6 of Schedule A) to: i. license, exhibit, distribute, reproduce, transmit, perform, display, and otherwise exploit and make available each Title within the Territory in any language by VOD (including SVOD, TVOD, AVOD and free VOD) for Internet, TV and mobile platforms (including, but not limited to, OTT streaming services, Sites and Mobile Sites), subject to these limitations for each of the Title in Schedule A1-A6: 1) For Titles listed in Schedule A1-A2: Licensor can only grant Licensee distribution rights to up to six (6) MSOs plus two (2) of China's Internet TV license holders or their OTT Internet-based video partners by VOD (including SVOD, TVOD, AVOD and free VOD). China's current Internet TV license holders include: CNTV (\u4e2d\u56fd\u7f51\u7edc\u7535\u89c6\u53f0/\u672a\u6765\u7535\u89c6), BesTV (\u767e\u89c6\u901a), Wasu (\u534e\u6570), Southern Media Cooperation (\u5357\u65b9\u4f20\u5a92), Hunan TV (\u8292\u679c TV), China National Radio/Galaxy Internet TV (GITV) (\u94f6\u6cb3\u7535\u89c6), and China Radio International (\u4e2d\u56fd\u56fd\u9645 \u5e7f\u64ad\u7535\u53f0);<omitted>2) For Titles listed in Schedule A3: For \"\u5929\u4e0b\u5973\u4eba\": No satellite TV broadcasting rights granted. Titles other than \"\u731c \u731c\u5973\u4eba\u5fc3\", \"\u8d4f\u6df1\u8d8a\u6155\" , \"\u804c\u573a\u65b0\u5973\u6027\u6311\u6218\u884c\u52a8\", \" \u6768\u6f9c\u8bbf\u8c08\u5f55\" (\u81ea\u7b2c192\u671f\u53ca\u4ee5\u540e\u7684\u8282 \u76ee),\"\u4eba\u751f\u76f8\u5bf9\u8bba \", \" \u5929\u4e0b\u5973\u4eba\", and \"\u6b63\u9752\u6625\" cannot be edited in any way; 3) For Titles listed in Schedule A4: Other than the versions (dubbed or translated) in which the Titles in Schedule A4 already exist in (and were delivered in), no further dubbing, translation, or editing may be performed by any party on Schedule A4's Titles. 4) For Titles listed in Schedule A5 (except \"Summer in February\"): Limitations on Rights Granted: the following distribution methods are permitted: non-theatrical, public video, ship and hotel rights (all not earlier than the US theatrical release); home video rental, home video sell through, and commercial video rights (all not earlier than the US video release); cable TV (pay & free), terrestrial TV (pay & free), satellite pay TV; internet TV (pay & free), residential and non-residential pay-per-view, residential and non-residential internet pay-per-view, VOD, near VOD, and internet VOD (all no earlier than the corresponding exploitation in the USA).",
            "target": "Yes",
            "document_name": "IdeanomicsInc_20160330_10-K_EX-10.26_9512211_EX-10.26_Content License Agreement.pdf",
            "index": 106
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Green Cross hereby grants to MacroGenics a non- exclusive, royalty-free, perpetual license, with the right to grant and authorize the grant of sublicenses, to use all Clinical Data and any data generated by Green Cross or any of its representatives or independent contractors pursuant to its performing its responsibilities under this Agreement for the research, Development, manufacture Commercialization and sales of MGAH22 and Products by MacroGenics outside the Territory and for MacroGenics to exercise its rights and fulfill its obligations under this Agreement.",
            "target": "Yes",
            "document_name": "MACROGENICSINC_08_02_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 107
        },
        {
            "input": "Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable license to any IP Controlled by Roche and developed under the ctDNA Platform Development Program (excluding Roche Immunotherapy Sample Results) to the extent necessary for FMI to research, develop, make, have made, use, offer for sale, sell, import and commercialize the ctDNA Assays.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 108
        },
        {
            "input": "Investor hereby agrees to grant to Company a non-exclusive, irrevocable, royalty-free license under any Joint Improvement and any patent claiming such Joint Improvement solely for use in rare earth mineral processing and rare earth separation.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 109
        },
        {
            "input": "Subject to the terms of this Agreement, subject to Manufacturer meeting EMV's requirements for quality, price and lead- time, EMV hereby grants Manufacturer an exclusive, non-transferable, license (without the right to sublicense) under EMV's Proprietary Rights in the Territory, during the term of this Agreement, to copy the EMV firmware as may be provided by EMV from time to time onto Product units in the manufacturing process at each EMV-approved Manufacturer manufacturing facility.",
            "target": "Yes",
            "document_name": "ELECTRAMECCANICA VEHICLES CORP. - Manufacturing Agreement .PDF",
            "index": 110
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Commerce One grants to Corio a nonexclusive, nontransferable (except in accordance with Section 14.1 of this Agreement), royalty-free, fully paid up, perpetual right and license in the Territory to reproduce, install and use additional copies of the Software and Software tools and utilities, subject to any restrictions placed on the Commerce One by third party software providers, in machine executable object code for (i) Corio's internal business operations and (ii) production, testing, development, upgrade, reporting and training.",
            "target": "Yes",
            "document_name": "CORIOINC_07_20_2000-EX-10.5-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 111
        },
        {
            "input": "In the event that any Bachem Intellectual Property is incorporated into any<omitted>deliverable (including Magenta Developed Intellectual Property (including Product)) or is otherwise necessary to fully exploit such deliverable, Bachem hereby grants to Magenta a perpetual, irrevocable, nonexclusive, worldwide, paid up, royalty-free license under such Bachem Intellectual Property (with the full right to sublicense directly or indirectly through multiple tiers) to (i) copy, distribute, display, perform and create derivative works of the Bachem Intellectual Property, in whole or in part; and (ii) to use Bachem Intellectual Property and/or practice the subject matter thereof, in each case solely in connection with manufacturing, marketing, promoting, using, selling, offering for sale, importing or distributing such deliverable (e.g., Product). Without limiting the foregoing, Magenta may use and disclose Bachem Intellectual Property to the extent necessary in",
            "target": "Yes",
            "document_name": "Magenta Therapeutics, Inc. - Master Development and Manufacturing Agreement.PDF",
            "index": 112
        },
        {
            "input": "Certegy hereby grants to Equifax a fully paid, non-exclusive, perpetual, worldwide license to use, modify, copy, improve and create Derivative Works and enhancements from, in source code and object code format, processes or procedures developed by Equifax in support to the Paynet Secure software product that have applicability independent of or from the Paynet Secure software produc",
            "target": "Yes",
            "document_name": "FIDELITYNATIONALINFORMATIONSERVICES,INC_08_05_2009-EX-10.3-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 113
        },
        {
            "input": "Franchisee agrees and grants to Pretzel Time and its Affiliates a perpetual and worldwide right to use and authorize other Pretzel Time Units or other food service businesses operated by Pretzel Time or its Affiliates, franchisees and designees to use such ideas, recipes, formulas, concepts, methods, and techniques relating to the development and/or operation of a dessert or snack food business.",
            "target": "Yes",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 114
        },
        {
            "input": "Hence, as of the Distribution Date, SpinCo hereby grants, and agrees to cause the members of the SpinCo Group to hereby grant, to Honeywell and the members of the Honeywell Group a non-exclusive, royalty-free, fully-paid, perpetual, sublicenseable (solely to Subsidiaries and suppliers for \"have made\" purposes), worldwide license to use and exercise rights under the SpinCo Shared IP (excluding Trademarks and the subject matter of any other Ancillary Agreement), said license being limited to use of a similar type, scope and extent as used in the Honeywell Business prior to the Distribution Date and the natural growth and development thereof.",
            "target": "Yes",
            "document_name": "GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement.pdf",
            "index": 115
        },
        {
            "input": "The Licensee hereby grants to the Licensor an irrevocable, non-exclusive, royalty-free, perpetual, worldwide license to use of any Licensee Know-how.",
            "target": "Yes",
            "document_name": "NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf",
            "index": 116
        },
        {
            "input": "To the extent not already granted pursuant to the License Agreement, FCE grants ExxonMobil and its Affiliates a worldwide, non-exclusive, royalty-free, irrevocable, perpetual, sub-licensable, non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice FCE Background Information and FCE Background Patents for Generation 2 Technology in Carbon Capture Applications and Hydrogen Applications.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 117
        },
        {
            "input": "(i) Subject to the terms and conditions of this Agreement, D2 hereby grants LICENSEE a perpetual non-exclusive, worldwide license, to use Licensed Technology in Object Code format only as an incorporated part of the Licensee Product.",
            "target": "Yes",
            "document_name": "SUMMAFOURINC_06_19_1998-EX-10.3-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 118
        },
        {
            "input": "Distributor hereby grants Zogenix an irrevocable, perpetual, world-wide, royalty-free, fully paid-up, non-exclusive license with the right to grant sublicenses under such Distributor Inventions and any patents or patent applications claiming or disclosing such Distributor Inventions.",
            "target": "Yes",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 119
        },
        {
            "input": "Effective as of the Initial Closing Date, the Seller hereby grants (and will cause each other Seller Party to grant following each applicable Closing Date) to the Purchaser Licensees: (A) for a period of one hundred eighty (180) days after the applicable Closing Date (the \"Mobility Transition Period\"), a fully paid-up, royalty-free, worldwide, non-transferable, non-exclusive sublicense to use any and all Mobility Trademarks, in accordance with the terms and conditions of the Mobility Trademark License; and (B) for a period of seven hundred thirty (730) days after the applicable Closing Date (the \"Non-Mobility Transition Period\"), a fully paid-up, royalty-free, irrevocable (except as expressly set forth herein), worldwide, non-transferable, non- exclusive license to use any and all Retained Seller Trademarks (other than the Mobility Trademarks and Licensed Trademarks) that are or have been, on or prior to the Initial Closing Date, used in connection with the Business or any product, service, or system in the Business (the \"Non-Mobility Trademarks\"), in each case of clauses (A) and (B), solely in connection with the operation of the Business or with the exercise of the licenses granted pursuant to Section 2.2(a) and Section 2.2(b), in a manner that is the same or substantially similar to the manner in which the Seller Entities used the Mobility Trademarks or Non-Mobility Trademarks, as applicable, in connection with the Business as of the Initial Closing Date, including with respect to existing signs and stocks of advertisements and promotional materials and items, inventory and packaging included in the Acquired Assets (\"Existing Stock\") containing any Mobility Trademark or Non- Mobility Trademark.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 120
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Arizona hereby grants to the Company a perpetual, non- exclusive, royalty-free license in, to and under the Arizona Licensed Know-How for use in the Company Field throughout the world.",
            "target": "Yes",
            "document_name": "ArmstrongFlooringInc_20190107_8-K_EX-10.2_11471795_EX-10.2_Intellectual Property Agreement.pdf",
            "index": 121
        },
        {
            "input": "The Consultant agrees that if, in the course of performing the Services, the Consultant incorporates into any Invention developed under this Agreement any preexisting invention, improvement, development, concept, discovery or other proprietary information owned by the Consultant or in which the Consultant has an interest (\"Prior Inventions\"), (i) the Consultant will inform the Company, in writing before incorporating such Prior Inventions into any Invention, and (ii) the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable worldwide license with the right to grant and authorize sublicenses, to make, have made, modify, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto.",
            "target": "Yes",
            "document_name": "PANDIONTHERAPEUTICSHOLDCOLLC_05_22_2020-EX-10.17-CONSULTING AGREEMENT.PDF",
            "index": 122
        },
        {
            "input": "Distributor hereby grants Zogenix an irrevocable, perpetual, royalty-free, fully paid-up, exclusive license with the right to grant sublicenses to use such Data solely generated and co-owned by Distributor outside of the Territory and a co-exclusive license in the Territory upon expiration or termination of the Agreement.",
            "target": "Yes",
            "document_name": "ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.pdf",
            "index": 123
        },
        {
            "input": "Notwithstanding the foregoing, for each end user that previously downloaded a Zynga game that includes WPT's Licensed Property, and stored such Zynga game within such end user's device, WPT grants a license and right to continue to use, activate, operate, perform, store, use and display that game on the end user's device in perpetuity at no additional charge; provided, however, that Zynga shall use best efforts to offer end users updates to its games which no longer include WPT's Licensed Property after the Term.",
            "target": "Yes",
            "document_name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.19_11788293_EX-10.19_Content License Agreement.pdf",
            "index": 124
        },
        {
            "input": "The term of the license for the Images delivered to HSWI as part of the Affinity, shall be perpetual and irrevocable.",
            "target": "Yes",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 125
        },
        {
            "input": "Upon Expiration of this Agreement: (i) the licenses granted to BLI from Ginkgo pursuant to Section 9.2 (Grants to BLI) and the licenses granted to Ginkgo from BLI in Section 9.1.1 (Scope of Grants) and 9.1.2 (License Grant to Exploit [***]) shall survive and become perpetual, irrevocable, and royalty-free, (ii) no royalties shall be payable by Ginkgo on the sale or transfer of a Licensed Product, (iii) the pricing terms for Beacon Optofluidic Machines, Consumables, and services (including Services) set forth in Section 5.2.2 (Pricing - Adjustments) shall [***], (iv) the restrictions on BLI set forth in Section 6.2.1 (Restrictions on BLI) shall survive to the extent set forth therein and (v) [***].",
            "target": "Yes",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 126
        },
        {
            "input": "Vendor hereby grants and promises to grant and have granted to AT&T and its Affiliates a royalty-free, nonexclusive, sublicensable, assignable, transferable, irrevocable, perpetual, world- wide license in and to any applicable Intellectual Property Rights of Vendor to use, copy, modify, distribute, display, perform, import, make, sell, offer to sell, and exploit (and have others do any of the foregoing on or for AT&T's or any of its customers' behalf or benefit) any Intellectual Property Rights of Vendor or any third party that are not included in Material or Paid-For Development but necessary to operate the Cell Sites or receive the full benefit of the Work.",
            "target": "Yes",
            "document_name": "AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement.pdf",
            "index": 127
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, Changepoint hereby grants to Corio a fee-bearing, irrevocable, nonexclusive, nontransferable (except in accordance with Section 14.1 of this Agreement) license in the Territory to (i) reproduce the Software in machine executable object code format only for installation on the Corio Servers; (ii) install multiple copies of the Software on Corio's Servers which will be made remotely accessible to Corio's Customers for their internal business purposes, (iii) permit limited access to and use of the Software by Customers through Corio Servers solely for such Customer's internal business purposes; (iv) sublicense an unlimited number of Customers to access and use the Software only through the installation on Corio Servers solely for such Customer's internal business purposes; and (v) use Changepoint's tools and utilities, if any, subject to any restrictions placed on the Changepoint by third party software providers and payment of any applicable fees required by such third parties, to configure, integrate and manage the Software.",
            "target": "Yes",
            "document_name": "CHANGEPOINTCORP_03_08_2000-EX-10.6-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 128
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, as of the Distribution Date, SpinCo hereby grants to Nuance and the members of the Nuance Group a worldwide, non-exclusive, fully paid-up, perpetual and irrevocable, transferable (subject to ARTICLE VIII), sublicensable (subject to Section 4.01(g)) license to continue to use any SpinCo IP (other than SpinCo Patents, SpinCo Technology Assets, SpinCo Trademarks, SpinCo Domain Names and SpinCo Data), in each case solely as and to the extent that it is used by the Nuance Group in connection with products and services of the Nuance Business within the Nuance Field of Use, together with natural extensions and evolutions thereof.",
            "target": "Yes",
            "document_name": "CerenceInc_20191002_8-K_EX-10.4_11827494_EX-10.4_Intellectual Property Agreement.pdf",
            "index": 129
        },
        {
            "input": "MD Anderson also hereby grants to Adaptimmune Limited an exclusive option to negotiate an<omitted>exclusive (subject to MD Anderson's perpetual, irrevocable, no-cost right to use such Invention for non-commercial internal research, academic and patient care purposes), royalty-bearing license to any Invention in which MD Anderson has an ownership interest, provided that Adaptimmune Limited pays all reasonably incurred patent expenses for such Invention in the event Adaptimmune Limited exercises its option.",
            "target": "Yes",
            "document_name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 130
        },
        {
            "input": "Upon expiration of this Agreement, the licenses granted to Ono under Section 2.1 shall become non-exclusive, fully paid- up, irrevocable, perpetual, royalty free licenses, with sublicensing rights, to Develop, Manufacture, and/or Commercialize the Products in the Ono Territory.",
            "target": "Yes",
            "document_name": "Array BioPharma Inc. - LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT.PDF",
            "index": 131
        },
        {
            "input": "IBM grants Customer an irrevocable, nonexclusive, worldwide, paid-up license to use, execute, reproduce, display, and perform copies of such Materials and distribute within Customer's Affiliates only.",
            "target": "Yes",
            "document_name": "QuantumGroupIncFl_20090120_8-K_EX-99.2_3672910_EX-99.2_Hosting Agreement.pdf",
            "index": 132
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-sub- licensable (except as set forth herein), perpetual, irrevocable (except as stated in Paragraphs 12.03 (Failure to Perform), 12.04 (Other Termination), and 12.05 (Bankruptcy)), non-transferable (except pursuant to Article 14 (Assignment)) right and license to practice ExxonMobil Background Information and ExxonMobil Background Patents for Generation 1 Technology in Carbon Capture Applications, solely to conduct Authorized Work with Authorized Third Parties.",
            "target": "Yes",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 133
        },
        {
            "input": "Upon the termination of this Agreement, the license granted in Section 6.11(c) above shall convert to a perpetual, non-exclusive, royalty-free, non-transferable and non-assignable license (without the right to sublicense, except as specifically set forth in Section 6.11(h) below) to use the Additional Roundup Products Formulation Data to make, sell and offer for sale, in the Included Markets for each such Additional Roundup Product, products comparable to such Additional Roundup Products, and to the limited extent necessary, to register such products with federal, state or territorial government authorities (as may be required by law) in the United States and its territories.",
            "target": "Yes",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 134
        },
        {
            "input": "Company grants to Investor, for the duration of the Option Period, a worldwide, royalty-free, non-exclusive, irrevocable license (with the right to grant sublicenses to Affiliates) under the Patents to practice the methods therein described and claimed and to make and have made, use, offer to sell, sell and import products made using such methods, and to make Improvements, and to engage in any activity which would give rise to a claim of infringement (direct or indirect or otherwise) of one or more of the Patents in the absence of a license.",
            "target": "Yes",
            "document_name": "RareElementResourcesLtd_20171019_SC 13D_EX-99.4_10897534_EX-99.4_Intellectual Property Agreement.pdf",
            "index": 135
        },
        {
            "input": "Effective as of the Initial Closing Date, the Seller hereby grants (and will cause each other Seller Party to grant, following each applicable Closing Date, to the Purchaser Licensees) a perpetual (unless terminated in accordance with Section 4.2(ii)(c)), fully paid-up, royalty-free, worldwide, non-transferable (except as set forth herein), non-exclusive license to use any and all Licensed Trademarks in the Business (including with respect to the Purchaser Licensed Activities), including with respect to all Derivative Works and natural evolutions of such Business, in a manner that is the same or substantially similar to the manner in which the Seller Entities have used the Licensed Trademarks in the Business.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 136
        },
        {
            "input": "Effective as of the Initial Closing Date the Seller hereby grants (and will cause each other Seller Party to grant, following each applicable Closing Date), to the Purchaser Licensees an irrevocable (except as expressly set forth herein), non-sublicenseable (except as expressly set forth herein), perpetual, fully paid-up, royalty-free, worldwide, non-transferable (except as expressly set forth herein), non-exclusive license, under the Licensed IP (other than Trademarks and Patents): (i) (A) to use such Licensed IP in the operation of the Business and to practice any methods, processes, and procedures in connection therewith and (B) to make, have made, use, sell, offer for sale, import, and otherwise dispose of products, services, and systems that were designed, developed, manufactured,<omitted>distributed, offered for sale, sold, resold, supported, otherwise under development, or provided, as of the applicable Closing Date, by the Seller Entities in connection with the Business and to practice any methods, processes, and procedures in connection therewith, and in each case of clauses (A) and (B), including with respect to all Derivative Works and natural evolutions thereof; and (ii) to make, have made, use, sell, offer for sale, import, and otherwise dispose of Smart Sensing Network Equipment.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 137
        },
        {
            "input": "Effective as of the Initial Closing Date, the Purchaser will cause each Acquired Company and each Purchaser Assignee to grant, following each applicable Closing Date, to the Seller Parties, an irrevocable (except as expressly set forth herein), perpetual, non-sublicenseable (except as expressly set forth herein), fully paid-up, royalty-free, worldwide, non-transferable (except as expressly set forth herein), non-exclusive license, under the Acquired Company Patents and Assigned Patents: (i) (A) to use the Acquired Company Patents and Assigned Patents in the operation of the Seller Business and to practice any methods, processes, and procedures in connection therewith and (B) to make, have made, use, sell, offer for sale, import, and otherwise dispose of products, services, and systems that were designed, developed, manufactured, distributed, offered for sale, sold, resold, supported, otherwise under development, or provided, as of the applicable Closing Date, by the Seller Parties in connection with the Seller Business and to practice any methods, processes, and procedures in connection therewith, and in each case of clauses (A) and (B), including with respect to all Derivative Works and natural evolutions thereof; 18 (ii) to make, have made, use, sell, offer for sale, import, and otherwise dispose of Smart Sensing Network Equipment; and (iii) to make, have made, use, sell, offer for sale, import, and otherwise dispose of Public Safety LTE Smartphone Devices.",
            "target": "Yes",
            "document_name": "ZEBRATECHNOLOGIESCORP_04_16_2014-EX-10.1-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 138
        },
        {
            "input": "PAPA JOHN'S hereby grants to ABG and CELEBRITY, a royalty-free, perpetual, irrevocable, fully- paid, assignable, transferable, sublicensable right and license to utilize the Materials, in their entirety or any portions thereof, in all media now known or hereafter developed, throughout the universe (individually and collectively, \"PJ Rights\") as follows: (i) on or in connection the performance of the Services hereunder; (ii) in connection with historical and archival purposes (e.g., documentary, commentary, corporate retrospective, historical files on websites of ABG), so-called business-to-business uses and other non-commercial purposes; and (iii) for industry recognition purposes (e.g., award competition submissions); in each case, in all media now known or hereafter devised.",
            "target": "Yes",
            "document_name": "PapaJohnsInternationalInc_20190617_8-K_EX-10.1_11707365_EX-10.1_Endorsement Agreement.pdf",
            "index": 139
        },
        {
            "input": "Upon termination or expiration of this Agreement, and upon reasonable prior notice to Network Affiliate, NCM shall be entitled to enter the Theatres upon reasonable prior written notice, and any other premises of Network Affiliate where any NCM Property may be located, and recover any and all NCM Property, unless Network Affiliate chooses to purchase such Property based on a straight line five year depreciated value.",
            "target": "No",
            "document_name": "DigitalCinemaDestinationsCorp_20111220_S-1_EX-10.10_7346719_EX-10.10_Affiliate Agreement.pdf",
            "index": 140
        },
        {
            "input": "The obligations of Affiliate and Network under this Agreement are subject to all applicable federal, state and local laws, rules and regulations, and this Agreement and all matters or issues collateral thereto shall be governed by the laws of the State of New York applicable to contracts to be entirely performed therein.",
            "target": "No",
            "document_name": "TubeMediaCorp_20060310_8-K_EX-10.1_513921_EX-10.1_Affiliate Agreement.pdf",
            "index": 141
        },
        {
            "input": "Negotiating in good faith, the Parties shall agree to a reasonable minimum percentage of Product supply to [***] Import Alert.",
            "target": "No",
            "document_name": "FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION.PDF",
            "index": 142
        },
        {
            "input": "Customer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Manufacturer-Owned Improvements and Developments to Manufacturer free and clear of any encumbrances, and Customer agrees to execute, and shall cause its Personnel and subcontractors to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country.",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 143
        },
        {
            "input": "Smith hereby grants to TDA the following rights (the \"Rights\"):<omitted>(d) the exclusive right to use and reuse the results and proceeds of the in connection with TDA's Golf Instruction Related Products;",
            "target": "No",
            "document_name": "HALITRON,INC_03_01_2005-EX-10.15-SPONSORSHIP AND DEVELOPMENT AGREEMENT.PDF",
            "index": 144
        },
        {
            "input": "In the event Fox provides such termination notice to Licensee, Licensee hereby grants Fox a license to the Licensee Materials in order for Fox to distribute the Wireless Products that Licensee has developed for distribution in Japan prior to such termination, either directly or through a third-party.",
            "target": "No",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement1.pdf",
            "index": 145
        },
        {
            "input": "This Agreement will be in effect for three (3) years from the Effective Date (\"Initial Term\") unless terminated earlier in accordance with this Agreement.",
            "target": "No",
            "document_name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.19_11788293_EX-10.19_Content License Agreement.pdf",
            "index": 146
        },
        {
            "input": "Party A's contribution to the registered capital of the Joint Venture Company shall be Fourteen Million Six Hundred Fifty-One Thousand United States Dollars (US$14,651,000), representing a forty-nine percent (49%) share of the Joint Venture Company's registered capital. Party B's contribution to the registered capital of the Joint Venture Company shall be Fifteen Million Two Hundred Forty Nine Thousand United States Dollars (US$15,249,000), representing a fifty-one percent (51%) share of the Joint Venture Company's registered capital.",
            "target": "No",
            "document_name": "VALENCETECHNOLOGYINC_02_14_2003-EX-10-JOINT VENTURE CONTRACT.PDF",
            "index": 147
        },
        {
            "input": "VerticalNet will pay PaperExchange ***** of the Equipment Listings Net Revenue.",
            "target": "No",
            "document_name": "PaperexchangeComInc_20000322_S-1A_EX-10.4_5202103_EX-10.4_Co-Branding Agreement.pdf",
            "index": 148
        },
        {
            "input": "Except as otherwise set forth in Sections 9.2 and 9.3 or Exhibit A hereof, the term of this Agreement shall be eighteen (18) months (\"Term\").",
            "target": "No",
            "document_name": "ON2TECHNOLOGIES,INC_11_17_2006-EX-10.3-SUPPORT AND MAINTENANCE AGREEMENT.PDF",
            "index": 149
        },
        {
            "input": "EXCEPT WITH RESPECT TO A MATERIAL BREACH CONSTITUTING WILLFUL MISCONDUCT BY A PROVIDER, REPEAT PERFORMANCE OF A SERVICE BY THE PROVIDER OR REFUND OF THE FEES PAID FOR A SERVICE SHALL BE THE SOLE AND EXCLUSIVE REMEDY FOR BREACH OF THE SERVICES STANDARD FOR SUCH SERVICE.",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20200121_S-1A_EX-10.22_11948918_EX-10.22_Service Agreement.pdf",
            "index": 150
        },
        {
            "input": "Upon termination of this Agreement and for a period of six (6) months thereafter, the Publishers will have the following rights and obligations: 33.1. Commencing upon any notice of termination by the Publishers, HealthGate will comply with the Publishers' reasonable directions, and will provide to the Publishers any and all termination assistance reasonably requested by the Publishers to allow the Services to continue and to facilitate the orderly transfer of responsibility for the Services to the Publishers or a successor provider of Services designated by the Publishers. The termination assistance to be provided to the Publishers by HealthGate may include the following: 33.1.1. Continuing to perform, for a reasonable period (as determined by the Publishers) of up to six (6) months following the termination date, any or all of the Services then being performed by HealthGate.",
            "target": "No",
            "document_name": "HEALTHGATEDATACORP_11_24_1999-EX-10.1-HOSTING AND MANAGEMENT AGREEMENT (1).pdf",
            "index": 151
        },
        {
            "input": "Except for breach of Article ------------------------------- VIII and for Article XII, in no event shall either Party be liable to the other Party for any indirect, incidental and/or consequential damages resulting from a breach of this agreement, including without limitation lost business, lost savings, and lost profits even if the breaching Party has been advised of the possibility of the occurrence of such damages.",
            "target": "No",
            "document_name": "ENTRUSTINC_07_24_1998-EX-10.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 152
        },
        {
            "input": "Workers' Compensation insurance with benefits afforded under the laws of any state in which the Work is to be performed and Employers Liability insurance with limits of at least: $500,000 for Bodily Injury - each accident $500,000 for Bodily Injury by disease - policy limits $500,000 for Bodily Injury by disease - each employee",
            "target": "No",
            "document_name": "AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement.pdf",
            "index": 153
        },
        {
            "input": "No party to this Agreement has the right to assign any of its rights or obligations hereunder, except as already set forth under this Agreement.",
            "target": "No",
            "document_name": "CcRealEstateIncomeFundadv_20181205_POS 8C_EX-99.(H)(3)_11447739_EX-99.(H)(3)_Marketing Agreement.pdf",
            "index": 154
        },
        {
            "input": "During the Term hereof and for a period of six (6) months following the termination of this Agreement or the discontinuation of any of the Company Products, (i) the Reseller shall have the exclusive right to commission for any Registered Referrals, (ii) the Company shall not market, promote, sell, or distribute Company Products or solicit or procure orders for the Company Products, or for any product(s) or service(s) similar to the Company Products, in the Territory other than through the Reseller and pursuant to this Agreement, except with the prior written consent of the Reseller, and (iii) without limitation to the foregoing, the Company shall not, directly or through other parties (whether agents, representatives, intermediaries, resellers or other parties), market, promote, sell, distribute, solicit or procure orders to any existing or prospective customer of the Reseller.",
            "target": "No",
            "document_name": "BravatekSolutionsInc_20170418_8-K_EX-10.1_10205739_EX-10.1_Reseller Agreement.pdf",
            "index": 155
        },
        {
            "input": "If the Quarterly Average Sales Force Size is less than [***] Sales Representatives for an applicable Calendar Quarter, then in calculating the promotion fee due under Section 6.1.1, the Applicable Percentage for such Calendar Quarter shall be reduced to a new percentage equal to [***].",
            "target": "No",
            "document_name": "DovaPharmaceuticalsInc_20181108_10-Q_EX-10.2_11414857_EX-10.2_Promotion Agreement.pdf",
            "index": 156
        },
        {
            "input": "We also have the right, at any time, to have an independent audit made of your books and records at our expense.",
            "target": "No",
            "document_name": "BUFFALOWILDWINGSINC_06_05_1998-EX-10.3-FRANCHISE AGREEMENT.PDF",
            "index": 157
        },
        {
            "input": "DGT's total liability, whether under the express or implied terms of this Agreement, in tort (including negligence), or at common law, for any loss or damage suffered by Dolphin, whether direct, indirect or special, or any other similar or like damage that may arise or does arise from any breaches of this Agreement by DGT and its Directors, Officers or agents, shall be limited to the amount of the cost of the products.",
            "target": "No",
            "document_name": "HUBEIMINKANGPHARMACEUTICALLTD_09_19_2006-EX-10.1-OUTSOURCING AGREEMENT.PDF",
            "index": 158
        },
        {
            "input": "The Company represents that, to the best of its knowledge, Products are in compliance with all laws, and that the Products will not be hazardous or dangerous when used for their intended purpose. Products do not cause harmful emissions or other environmental hazards and Products do not violate or infringe any patents, copyrights, trademarks or other rights of nay third party(ies).",
            "target": "No",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 159
        },
        {
            "input": "Party A shall not establish any same or similar cooperative relationship with any third party in respect of such businesses nor shall it make any same or similar arrangement, unless with the prior written consent of Party B.",
            "target": "No",
            "document_name": "TUNIUCORP_03_06_2014-EX-10-COOPERATION AGREEMENT.PDF",
            "index": 160
        },
        {
            "input": "The AS Parties shall have the right, upon at least five (5) days written notice and no more than once each Contract Year of the Term to inspect MusclePharm's books and records and all other documents and material in the possession of or under the control of MusclePharm with respect to the Licensed Products at the place or places where such records are normally retained by MusclePharm",
            "target": "No",
            "document_name": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
            "index": 161
        },
        {
            "input": "All inventions, ideas, creations, discoveries, computer programs, works of authorship, data, developments, technology, designs, innovations and improvements (whether or not patentable and whether or not copyrightable) which are made, conceived, reduced to practice, created, written, designed or developed by the Consultant, solely or jointly with others or under Consultant's direction and whether during normal business hours or otherwise, (i) during the Consultation Period if related to the business of the Company or (ii) during or after the Consultation Period if resulting or directly derived from Proprietary Information (as defined above) (collectively under clauses (i) and (ii), \"Inventions\"), shall be the sole property of the Company.",
            "target": "No",
            "document_name": "PANDIONTHERAPEUTICSHOLDCOLLC_05_22_2020-EX-10.17-CONSULTING AGREEMENT.PDF",
            "index": 162
        },
        {
            "input": "All such records shall be subject to inspection by an independent auditor designated by CERES and reasonably acceptable to IGER within normal business hours with at least fourteen (14) days notice.",
            "target": "No",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 163
        },
        {
            "input": "The term \"Specified Minimum Percentage\" shall be equal to the percentage set forth on Schedule 1 attached hereto, which shall be agreed to by AIG and the Company at least once every year beginning upon the date of the filing of the Company's 2014 Annual Statement with the Domiciliary State's insurance department and following review against the capital adequacy standards and criteria (\"Agency Criteria\") of each of Standard & Poor's Corp. (\"S&P\"), Moody's Investors Service (\"Moody's\") and A.M. Best Company (\"A.M. Best\").<omitted>The Specified Minimum Percentage shall equal 385% of the Company's Company Action Level RBC.",
            "target": "No",
            "document_name": "VARIABLESEPARATEACCOUNT_04_30_2014-EX-13.C-UNCONDITIONAL CAPITAL MAINTENANCE AGREEMENT.PDF",
            "index": 164
        },
        {
            "input": "Except as agreed by the Parties in writing or as otherwise stated in the Exhibits, Company may terminate for convenience any Transition Service, and RGHI may terminate for convenience any Reverse Transition Service, upon 30 days' prior written notice of such termination; provided, (a) that, with respect to the Services described in Section G1 of Exhibit A, unless otherwise indicated therein, those Services may not be terminated independently except in accordance with an agreed Migration Plan and, (b) any unamortized costs associated with Provider's purchase of any license or other costs incurred specifically for the purpose of providing the Services hereunder will be passed through to the Terminating Party.",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20200121_S-1A_EX-10.22_11948918_EX-10.22_Service Agreement.pdf",
            "index": 165
        },
        {
            "input": "This includes in particular the liability exclusion for lost profit, the loss of data or interruption to or errors in the operation of the Web site of the Affiliate.",
            "target": "No",
            "document_name": "SouthernStarEnergyInc_20051202_SB-2A_EX-9_801890_EX-9_Affiliate Agreement.pdf",
            "index": 166
        },
        {
            "input": "Either party may terminate this Agreement prior to expiration of the Term: (i) upon thirty (30) days prior written notice, or (ii) immediately upon written notice to the other party if: (a) the other party declares or a petition is filed in any court for insolvency or bankruptcy and such petition is not dismissed in thirty (30) days; (b) the other party reorganizes under the relevant bankruptcy act or any similar statute in such party's jurisdiction of incorporation; (c) the other party consents to the appointment of a trustee in bankruptcy or a receiver or similar entity; or (d) the Developer breaches DSS's Technology or Intellectual Property rights contained herein.",
            "target": "No",
            "document_name": "HfEnterprisesInc_20191223_S-1_EX-10.22_11931299_EX-10.22_Development Agreement.pdf",
            "index": 167
        },
        {
            "input": "Racing shall also provide comprehensive (fire and theft) and collision insurance on each vehicle used in the Business.",
            "target": "No",
            "document_name": "GAINSCOINC_01_21_2010-EX-10.41-SPONSORSHIP AGREEMENT.PDF",
            "index": 168
        },
        {
            "input": "MBRK may terminate this Agreement upon 60 days notice for a Change of Control subject to the Fees outlined in paragraph (f) of this Section 18.",
            "target": "No",
            "document_name": "MIDDLEBROOKPHARMACEUTICALS,INC_03_18_2010-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 169
        },
        {
            "input": "As of the Termination Date, EFS shall not process any new orders placed through the Playboy Commerce Business. Notwithstanding the foregoing, EFS may fulfill any outstanding orders placed through the Playboy Commerce Business prior to the Termination Date and may continue collection activities related thereto, which shall be subject to Section 6 hereof.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 170
        },
        {
            "input": "This non-compete provision may not be enforceable under the laws of your state.",
            "target": "No",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 171
        },
        {
            "input": "MA is authorized to resell Technology within the following territory according to the terms of the Agreement: Worldwide",
            "target": "No",
            "document_name": "CybergyHoldingsInc_20140520_10-Q_EX-10.27_8605784_EX-10.27_Affiliate Agreement.pdf",
            "index": 172
        },
        {
            "input": "Pursuant to and in accordance with Section 5-1401 of the New York General Obligations Law, the Parties hereto agree that this Amendment in all respects, and any claim or cause of action based upon or arising out of this Amendment, or any dealing between the Parties relating to the subject matter of this Amendment or the transactions contemplated hereby or the Company/Repairer relationship being established, shall be governed by, and construed in accordance with, the laws of the State of New York, U.S.A. as applied to contracts to be performed wholly within the State of New York (Exclusive of Section 7-101 of the New York General Obligations Law which is inapplicable to this Amendment).",
            "target": "No",
            "document_name": "AzulSa_20170303_F-1A_EX-10.3_9943903_EX-10.3_Maintenance Agreement2.pdf",
            "index": 173
        },
        {
            "input": "The occurrence of any one of the following events shall constitute a default under this Agreement requiring a 30 day notice period of termination by Pretzel Time to Franchisee:<omitted>(xi) Franchisee misuses Pretzel Time's Marks or asserts any interest in Pretzel Time's Marks; uses Pretzel Time's tradename or any part thereof as part to of its corporate name; does not cooperate in the enforcement of any Mark; or challenges or seeks to challenge the validity of the Marks;",
            "target": "No",
            "document_name": "MRSFIELDSORIGINALCOOKIESINC_01_29_1998-EX-10-FRANCHISE AGREEMENT.PDF",
            "index": 174
        },
        {
            "input": "It is the cumulative maximum for which IBM and its Affiliates and Subcontractors are collectively responsible.",
            "target": "No",
            "document_name": "QuantumGroupIncFl_20090120_8-K_EX-99.2_3672910_EX-99.2_Hosting Agreement.pdf",
            "index": 175
        },
        {
            "input": "Subject to Section 7.4, Manufacturer may, without Customer's consent, assign the rights and obligations of this Agreement (i) on a Facility-by-Facility basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of such Facility or (ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Manufacturer to which this Agreement and the Facility Addendum relates (including in connection with such business's spin-off, merger or consolidation with another company or business entity).",
            "target": "No",
            "document_name": "UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.pdf",
            "index": 176
        },
        {
            "input": "Effective Date means May 3, 200ri or such later date as determined under the Arrangement Agreement,",
            "target": "No",
            "document_name": "WESTERN COPPER - NON-COMPETITION AGREEMENT.PDF",
            "index": 177
        },
        {
            "input": "Cisco's policy is that Software, whether Standalone or Embedded, is not transferable, except where a listed exception below applies, and except, of course, where Cisco's contract expressly allows it.",
            "target": "No",
            "document_name": "ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1.pdf",
            "index": 178
        },
        {
            "input": "In connection with all significant construction, reconstruction, or remodeling of the Franchised Business during the term of this Agreement, you agree to require the general contractor, its subcontractors, and any other contractor, to effect and maintain at general contractor's and all other contractor's own expense, such insurance policies and bonds with such endorsements as are set forth in the Manual, all written by insurance or bonding companies that we have approved, having a rating as set forth in Section 15.1 above.",
            "target": "No",
            "document_name": "GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.PDF",
            "index": 179
        },
        {
            "input": "The parties agree that the records maintained and produced under this Agreement shall, at all times, be available at the Operations Center for examination and audit by governmental agencies having jurisdiction over the Customer's business, including any Federal, State or Puerto Rico Regulator.",
            "target": "No",
            "document_name": "OFGBANCORP_03_28_2007-EX-10.23-OUTSOURCING AGREEMENT.PDF",
            "index": 180
        },
        {
            "input": "Notwithstanding anything contained herein to the contrary, the indemnifying party's liability to the other hereunder shall not exceed the insurance coverage set out in Section 9.0.",
            "target": "No",
            "document_name": "DYNAMEXINC_06_06_1996-EX-10.4-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 181
        },
        {
            "input": "ach such insurance policy and endorsement shall provide that the insurance will not be canceled or reduces without at least thirty (30) days' prior written notice to STAAR.",
            "target": "No",
            "document_name": "StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement.pdf",
            "index": 182
        },
        {
            "input": "For monthly Cash Sales above [$\u25cf] and up to [$\u25cf], the Base Royalty paid to T&B by LEA shall be [\u25cf%] of the LEA's Cash Sales",
            "target": "No",
            "document_name": "LegacyEducationAllianceInc_20200330_10-K_EX-10.18_12090678_EX-10.18_Development Agreement.pdf",
            "index": 183
        },
        {
            "input": "During the Term and for a period of two (2) years after any expiration or termination of this Agreement, each party shall maintain (i) a commercial general liability insurance policy or policies with minimum limits of $[***] per occurrence and $[***] in the aggregate on an annual basis and (ii) a product liability insurance policy or policies with minimum limits of $[***] per occurrence and $[***] in the aggregate on an annual basis; provided that the minimum product liability policy limits set forth above shall be increased to at least $[***] per occurrence and $[***] in the aggregate on an annual basis no later than December 31, 2006.",
            "target": "No",
            "document_name": "KINGPHARMACEUTICALSINC_08_09_2006-EX-10.1-PROMOTION AGREEMENT.PDF",
            "index": 184
        },
        {
            "input": "The parties hereby grant to each other non-exclusive, fully-paid, royalty-free licenses to utilize the other party's trademarks, as follows: (a) Biocept Trademarks. To facilitate the promotion and performance of Tests, during the Term Biocept hereby grants Life Technologies a non-exclusive, royalty-free, non-transferable license to use the Biocept Trademarks solely for<omitted>use in connection with the promotion and performance of the Tests in the Territory.",
            "target": "No",
            "document_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.PDF",
            "index": 185
        },
        {
            "input": "The foregoing shall be Bellicum's sole and exclusive remedy and Miltenyi's sole obligation with respect to claims that any Miltenyi Product fails to comply with the Miltenyi Product Warranty or the warranties in Section 11.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 186
        },
        {
            "input": "This Agreement shall be governed by and be --------- ---- construed in accordance with the laws of the Province of Ontario, Canada.",
            "target": "No",
            "document_name": "ENTRUSTINC_07_24_1998-EX-10.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 187
        },
        {
            "input": "The rights granted hereunder shall be effective as of the Effective Date and shall expire on December 31, 2006 (the \"Term\"); provided, however, that with respect to each Property, all rights and licenses granted herein will continue in full force and effect for a period of eighteen (18) months after the initial theatrical release of that Property.",
            "target": "No",
            "document_name": "GluMobileInc_20070319_S-1A_EX-10.09_436630_EX-10.09_Content License Agreement1.pdf",
            "index": 188
        },
        {
            "input": "LeadersOnline shall pay VerticalNet *** percent (***%) of LeadersOnline- VerticalNet Revenue, payable to VerticalNet on or before the fifteenth day of the calendar month immediately following the month in which<omitted>such revenue was received by LeadersOnline.",
            "target": "No",
            "document_name": "LeadersonlineInc_20000427_S-1A_EX-10.8_4991089_EX-10.8_Co-Branding Agreement.pdf",
            "index": 189
        },
        {
            "input": "Endorser also grants to MusclePharm and consents to MusclePharm's editorial use world-wide of Endorser's Name and Appearance in MusclePharm published materials approved by Endorser. For purposes of this Agreement, MusclePharm's editorial use of Endorser's Name and Appearance shall mean a use that does not directly promote, advertise or endorse MusclePharm's business, its Products or Licensed Products. Nothing in this Section 6(c) shall entitle MusclePharm to reduce Endorser's compensation pursuant to Section 7 and Section 8 of this Agreement (including, without limitation, with respect to any renewal Term, if any).",
            "target": "No",
            "document_name": "MusclepharmCorp_20170208_10-KA_EX-10.38_9893581_EX-10.38_Co-Branding Agreement.pdf",
            "index": 190
        },
        {
            "input": "Owner shall have up until two years after the close of a Calendar Year in which to make an audit of Operator's records for such Calendar Year.",
            "target": "No",
            "document_name": "SANDRIDGEENERGYINC_08_06_2009-EX-10.6-OPERATIONS AND MAINTENANCE AGREEMENT.PDF",
            "index": 191
        },
        {
            "input": "E.piphany warrants that for a period of one (1) year from Effective Date, the Application as used within the scope of this Agreement will perform substantially in accordance with the functions described in the Documentation.",
            "target": "No",
            "document_name": "OASYSMOBILE,INC_07_05_2001-EX-10.17-OUTSOURCING AGREEMENT.PDF",
            "index": 192
        },
        {
            "input": "Oceanic Time Warner Cable will use the content solely on channel 777, the Las Vegas channel.",
            "target": "No",
            "document_name": "WatchitMediaInc_20061201_8-K_EX-10.1_4148672_EX-10.1_Content License Agreement.pdf",
            "index": 193
        },
        {
            "input": "Each party shall carry appropriate and commercially reasonable amounts of insurance adequate for the activities detailed in this Agreement, as well as sufficient levels of all legally mandated insurance, if any.",
            "target": "No",
            "document_name": "TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.pdf",
            "index": 194
        },
        {
            "input": "In the event that Company is unable or unwilling to promptly perform any warranty work without reasonable cause and following full and fair opportunity to do so, or in the event of the necessity for emergency repairs of a defective Product for which there is no reasonable possibility of performance by Company, Distributor may perform such warranty work or hire a third party to perform such warranty work and the reasonable cost thereof shall be paid by Company.",
            "target": "No",
            "document_name": "LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.PDF",
            "index": 195
        },
        {
            "input": "ExxonMobil grants FCE a worldwide, non-exclusive, royalty-free, non-transferable (except pursuant to Article 14 (Assignment)), non-sub-licensable (except as set forth in this Paragraph 7.01(a)) right and license to practice Program Results solely to conduct research and development for the Program.",
            "target": "No",
            "document_name": "FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf",
            "index": 196
        },
        {
            "input": "However, no assignment shall be effective until such time as Franchisor or its designated affiliate gives Lessor written notice of its acceptance of the assignment, and nothing contained herein or in any other document shall constitute Franchisor or its designated subsidiary or affiliate a party to the Lease Agreement, or guarantor thereof, and shall not create any liability or obligation of Franchisor or its parent unless and until the Lease Agreement is assigned to, and accepted in writing by, Franchisor or its parent, subsidiary or affiliate.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 197
        },
        {
            "input": "During the term of this Agreement, Ono shall pay to Array, on a quarterly basis, a royalty on the Net Sales of Products by Ono, its Affiliates or Sublicensees.",
            "target": "No",
            "document_name": "Array BioPharma Inc. - LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT.PDF",
            "index": 198
        },
        {
            "input": "During the Term of this Agreement, either Party may request an increase or decrease of the Fees specified in Exhibit C no more than [* * *] and such change in Fees shall take effect on [* * *] for which such Fee change is requested.",
            "target": "No",
            "document_name": "ParatekPharmaceuticalsInc_20170505_10-KA_EX-10.29_10323872_EX-10.29_Outsourcing Agreement.pdf",
            "index": 199
        },
        {
            "input": "[***] shall designate up to [***] ([***]) BLI employees or personnel as key persons (individually, a \"Key Person\" and collectively, \"Key Persons\").",
            "target": "No",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 200
        },
        {
            "input": "If the Sponsor decides not to be the category sponsor of the 2016 Event or fails to timely respond to the Notice, then ANTHEMIC may approach other parties to be the category sponsor.",
            "target": "No",
            "document_name": "VNUE,INC_07_10_2015-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 201
        },
        {
            "input": "During reasonable business hours IMPCO and MIL/MINDA will have the right to visit, enter and inspect each plant and other establishment at which the JVC manufactures and/or processes the Products. In exercising such right, the Parties will be reasonable.",
            "target": "No",
            "document_name": "IMPCOTECHNOLOGIESINC_04_15_2003-EX-10.65-JOINT VENTURE AGREEMENT.PDF",
            "index": 202
        },
        {
            "input": "The Term of this Agreement shall be for a period of [* ****] years and [*****] months commencing the 1st day of September 2004 and terminating the [*****] day of [*****].",
            "target": "No",
            "document_name": "ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT.PDF",
            "index": 203
        },
        {
            "input": "In the event the Closing fails to occur, then, only upon entry of a final and non-appealable order of the Bankruptcy Court determining that such failure was the result of Purchaser's sole, material, non-excusable breach of this Agreement, then Merchant shall be entitled to retain the Deposit as liquidated damages as Merchant's sole remedy for such breach.",
            "target": "No",
            "document_name": "BONTONSTORESINC_04_20_2018-EX-99.3-AGENCY AGREEMENT.PDF",
            "index": 204
        },
        {
            "input": "Theismann shall have the right to terminate this Agreement at any time upon thirty (30) days' written notice to Bizzingo, such termination to become effective at the conclusion of such 30-day period.",
            "target": "No",
            "document_name": "BizzingoInc_20120322_8-K_EX-10.17_7504499_EX-10.17_Endorsement Agreement.pdf",
            "index": 205
        },
        {
            "input": "The term of this Agreement (the \"Term\") shall commence on the date hereof (the \"Effective Date\") and shall expire upon delivery of [**] to ebix, but in no way shall this Agreement extend any later than thirty (30) months from the Effective Date regardless of the number Filled Application Forms delivered to ebix. About will make commercially reasonable efforts to achieve that number in twelve (12) months or less from the Effective Date.",
            "target": "No",
            "document_name": "EbixInc_20010515_10-Q_EX-10.3_4049767_EX-10.3_Co-Branding Agreement.pdf",
            "index": 206
        },
        {
            "input": "MSL agrees to provide the audit or inspection team reasonable access to the relevant MSL's and/or MSL's Subsidiaries' records and facilities for the purpose of performing the audit.",
            "target": "No",
            "document_name": "MANUFACTURERSSERVICESLTD_06_05_2000-EX-10.14-OUTSOURCING AGREEMENT.PDF",
            "index": 207
        },
        {
            "input": "MKOS will have 30-days from receipt of information to determine if they wish to go forward with the technology license. UTEK, after 30 days, shall have the right to present the technology to other clients.",
            "target": "No",
            "document_name": "MANAKOASERVICESCORP_11_21_2007-EX-7.5-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 208
        },
        {
            "input": "Within 30 days after the Effective Date, VerticalNet shall provide a copy of all VerticalNet Medical Product Listings for New Medical Products existing as of the Effective Date to Neoforma for use on Neoforma Plan, Neoforma Shop and Neoforma Auction on an exclusive basis (even as to VerticalNet), to the extent VerticalNet has the right to do so.",
            "target": "No",
            "document_name": "NeoformaInc_19991202_S-1A_EX-10.26_5224521_EX-10.26_Co-Branding Agreement.pdf",
            "index": 209
        },
        {
            "input": "At Rogers' option, this Agreement shall renew for a subsequent term of two (2) years on the terms and conditions herein (the \"Renewal Term\").",
            "target": "No",
            "document_name": "EuromediaHoldingsCorp_20070215_10SB12G_EX-10.B(01)_525118_EX-10.B(01)_Content License Agreement.pdf",
            "index": 210
        },
        {
            "input": "The Company and Online BVI each assign to Skype, with full title guarantee, all copyrights, patents, trade marks, service marks, rights of publicity, authors' rights, contract and licensing rights, goodwill and all other intellectual property rights in and to the foregoing translations as may exist now and/or hereafter come into existence and arising under the laws of any jurisdiction for the entire term of such rights and all renewals, revivals and extensions thereof.",
            "target": "No",
            "document_name": "TomOnlineInc_20060501_20-F_EX-4.46_749700_EX-4.46_Co-Branding Agreement.pdf",
            "index": 211
        },
        {
            "input": "EXCEPT FOR BREACH OF CONFIDENTIALITY OBLIGATION HEREUNDER, AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF USE, DATA OR LOST PROFITS, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, WHETHER UNDER THIS AGREEMENT, IN TORT OR OTHERWISE.",
            "target": "No",
            "document_name": "MEDIWOUNDLTD_01_15_2014-EX-10.6-SUPPLY AGREEMENT.PDF",
            "index": 212
        },
        {
            "input": "A Party that breaches this Agreement will only be liable to the other Party for direct damages arising from the breach.",
            "target": "No",
            "document_name": "ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement.pdf",
            "index": 213
        },
        {
            "input": "If DIALOG decides to discontinue Sales of any Product, it will notify ENERGOUS at least [***] prior to such discontinuance, and following such notification, the exclusivity rights, if any, associated with that Product will cease; provided, however, this provision will not apply in the event that DIALOG continues Sales of Product Updates, repackaged Product Dies or MCMs.",
            "target": "No",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 214
        },
        {
            "input": "We grant to you and you accept a limited, non-exclusive License to use the Marks and the System during the Term at, and in connection with, the operation of the Hotel in accordance with the terms of this Agreement.",
            "target": "No",
            "document_name": "HOSPITALITYINVESTORSTRUST,INC_04_07_2014-EX-10.26-FRANCHISE AGREEMENT.PDF",
            "index": 215
        },
        {
            "input": "Bachem shall provide, and shall cause its Affiliates and sublicensees who perform activities in connection with the manufacture of Product to provide, to Magenta, upon its reasonable request, a statement of coverages, amounts of insurance, and deductibles, and a copy of all policies including clauses within the policies that the insurance company has a duty to defend and indemnify.",
            "target": "No",
            "document_name": "Magenta Therapeutics, Inc. - Master Development and Manufacturing Agreement.PDF",
            "index": 216
        },
        {
            "input": "In the event any sale is made at a special price to any of Diplomat's subsidiaries or to any other person, firm or corporation related in any manner to Diplomat or its officers, directors or major stockholders, there shall be a royalty paid on such sales based upon the price generally charged the trade by Diplomat.",
            "target": "No",
            "document_name": "AMBASSADOREYEWEARGROUPINC_11_17_1997-EX-10.28-ENDORSEMENT AGREEMENT.PDF",
            "index": 217
        },
        {
            "input": "This Letter of Authorization will be governed by and construed in accordance with the laws of California, excluding its conflict of laws provisions, and be subject to the non-exclusive jurisdiction of the California courts.",
            "target": "No",
            "document_name": "ENERGOUSCORP_03_16_2017-EX-10.24-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 218
        },
        {
            "input": "IN NO EVENT WILL CONTENT PROVIDER BE LIABLE TO COMPANY NOR WILL COMPANY BE LIABLE TO CONTENT PROVIDER FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. TH LIABILITY OF CONTENT PROVIDER FOR DAMAGES HEREUNDER, WHETHER IN CONTRACT, TORT<omitted>OR ANY OTHER LEGAL THEORY, IS LIMITED TO, AND SHALL NOT EXCEED $31,200.00.",
            "target": "No",
            "document_name": "MidwestEnergyEmissionsCorp_20080604_8-K_EX-10.2_3093976_EX-10.2_Content License Agreement.pdf",
            "index": 219
        },
        {
            "input": "Neither party may assign this Agreement or any rights or obligations hereunder, whether by operation of law or otherwise, without the prior written consent of the other party.",
            "target": "No",
            "document_name": "CORIOINC_07_20_2000-EX-10.5-LICENSE AND HOSTING AGREEMENT.PDF",
            "index": 220
        },
        {
            "input": "Licensor shall assume no liability, both contingent and otherwise, which may arise out of or be in any way related to the following; (a) furnishing, performance, maintenance, use of, or inability to use all or any part of the system, (b) any fault in the delivery or operation of the system, (c) suspension or termination of the Licensee's ability to use all or part of the system, or any inaccuracies or omissions in any information or documentation provided, (d) any failure or delay suffered or allegedly suffered by Licensee in initiating and terminating trades, (e) the termination of all or part of this Licensee Agreement by the Licensor, (f) the termination or modification of any and all parts of the License.",
            "target": "No",
            "document_name": "SFGFINANCIALCORP_05_12_2009-EX-10.1-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 221
        },
        {
            "input": "Except as may otherwise be provided in this Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Agreement.",
            "target": "No",
            "document_name": "DRIVENDELIVERIES,INC_05_22_2020-EX-10.4-CONSULTING AGREEMENT.PDF",
            "index": 222
        },
        {
            "input": "If the vendor's minimum order quantity for a particular material exceeds a [***] supply, then Heritage shall obtain permission from Premier to order such quantity.",
            "target": "No",
            "document_name": "BellringBrandsInc_20190920_S-1_EX-10.12_11817081_EX-10.12_Manufacturing Agreement1.pdf",
            "index": 223
        },
        {
            "input": "This Agreement will be effective beginning on 12:01 a.m., Eastern Time, on the day after the date of last signature to these Base Terms (\"Effective Date\") and ending on the expiration and/or termination of all Service Option Attachments, unless the Agreement is terminated earlier in accordance with the terms herein.",
            "target": "No",
            "document_name": "BLUEFLYINC_03_27_2002-EX-10.27-e-business Hosting Agreement.PDF",
            "index": 224
        },
        {
            "input": "During the Term and for a period of [***] ([***]) months following the Term of this Agreement, other than pursuant to Sections 13.3.2 (Effects of Termination Based Upon Ginkgo's Buy-Down Election) or 13.3.3 (Effects of Termination Based Upon an Uncured Ginkgo Breach, Insolvency or Force Majeure Event), BLI shall not, and shall cause its Affiliates not to, directly or indirectly, itself or with or through a Third Party, develop, configure, customize, license, sell, provide or otherwise give access to the Beacon Platform or any [***] to, [***] or its Affiliates for any use; provided that this restriction shall terminate as set forth in Section 13.3 (Effects of Expiration or Termination) or if Ginkgo has not satisfied its Minimum Cumulative Purchase Commitments (as such may be adjusted under this Agreement) for a full Contract Year, including [***] as permitted under Section 7.2.2(a) (Minimum Cumulative Purchase Commitments) or Section 7.2.2(b)(iii) (Development Purchase Commitments); provided that BLI will provide written notice to Ginkgo within [***] ([***]) days of the end of any Contract Year with respect to which BLI believes that Ginkgo has not satisfied its Minimum Cumulative Purchase Commitment.",
            "target": "No",
            "document_name": "BERKELEYLIGHTS,INC_06_26_2020-EX-10.12-COLLABORATION AGREEMENT.PDF",
            "index": 225
        },
        {
            "input": "The parties acknowledge that the foregoing will not prevent CNET from displaying text links and other references to Competing Computer Products Retailers as reasonably necessary to provide appropriate editorial and search related services on the CNET Sites. The Retail Promotions granted to the Company shall be placed in such a way as to provide no more or less prominence to the Company than is provided to any other Competing Computer Retailer signing an agreement with CNET.",
            "target": "No",
            "document_name": "CYBERIANOUTPOSTINC_07_09_1998-EX-10.13-PROMOTION AGREEMENT.PDF",
            "index": 226
        },
        {
            "input": "Each such subcontractor listed on Exhibit A attached hereto and any Affiliate or Third Party approved by SIGA as an MMT sublicensee pursuant to this Section 2.1(b) shall be deemed to be a \"Permitted Sublicensee\" for purposes of this Agreement.",
            "target": "No",
            "document_name": "SigaTechnologiesInc_20190603_8-K_EX-10.1_11695818_EX-10.1_Promotion Agreement.pdf",
            "index": 227
        },
        {
            "input": "This Agreement shall be governed and construed in accordance with the laws of the state of Texas without giving effect to the conflict of law rules thereof.",
            "target": "No",
            "document_name": "RangeResourcesLouisianaInc_20150417_8-K_EX-10.5_9045501_EX-10.5_Transportation Agreement.pdf",
            "index": 228
        },
        {
            "input": "A Participant will not be liable to the Joint Venture, or to any other Participant, for any mistake or error in judgment or for any act or omission done in good faith and believed to be within the scope of authority conferred or implied by this Agreement or the Joint Venture.",
            "target": "No",
            "document_name": "MJBIOTECH,INC_12_06_2018-EX-99.01-JOINT VENTURE AGREEMENT.PDF",
            "index": 229
        },
        {
            "input": "All Joint Inventions shall be jointly owned by the Parties, and Patents Covering Joint Inventions shall be referred to as \"Joint Collaboration Patents\".",
            "target": "No",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 230
        },
        {
            "input": "Any such audit shall be conducted by an independent certified public accounting firm which is not engaged in performing other work for World Book or its affiliates; which agrees to enter into a confidentiality agreement with HSWI; and which is not compensated in any manner of contingency arrangements on the basis of its findings.",
            "target": "No",
            "document_name": "RemarkHoldingsInc_20081114_10-Q_EX-10.24_2895649_EX-10.24_Content License Agreement.pdf",
            "index": 231
        },
        {
            "input": "This Agreement will automatically renew for up to two (2) renewal terms of five (5) years each (each, an \"Extension Period\") unless either Party provides the other Party with written notice of its intent to terminate this Agreement at least six (6) months prior to the end of the Initial Term or the then current Extension Period.",
            "target": "No",
            "document_name": "MPLXLP_06_17_2015-EX-10.1-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 232
        },
        {
            "input": "In the case of termination by Monsanto upon any of the Events of Default specified in Sections 10.4(b) (6), (7) and (9), the remedies of Monsanto shall be limited to (i) termination of this Agreement and (ii) the recovery of reasonable and customary out-of-pocket expenses incurred by Monsanto in transferring the Agent's duties hereunder to a new agent; provided that in no case shall the amount of expenses recoverable under this provision exceed $20MM.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 233
        },
        {
            "input": "Neither the Farids Group nor any of its Affiliates shall in any manner, directly or indirectly, in any capacity or manner, make or cause to be made, or in any way encourage any other person to make or cause to be made, any public statement or public announcement, including in any document or report filed with or furnished to the SEC or through the press, media, analysts or other persons, that constitutes an ad hominem attack on or otherwise disparages, defames or slanders the Company or any of its Affiliates or any of their respective successors or current or former members, partners, officers, directors or employees; provided, that, the limitations set forth in this Section 8.8(b) shall not prevent the Farids Group or any of its Affiliates from (i) responding to any statement made by the Company or any of its Affiliates or representatives that was made in breach of Section 8.8(a) above or (ii) if solicited by a Third Party, making objective statements that reflect the Farids Group's or any of its Affiliates' view with respect to factual matters concerning specific acts or determinations of the Company, any of its Affiliates or any current or former representatives of the Company or any of its Affiliates occurring after the date hereof. For the avoidance of doubt, a public statement or announcement shall only be deemed to be made by the Farids Group or any of its Affiliates if such public statement or announcement is made by (X) a Farids manager, director or executive officer or an EA manager, director or executive officer (Y) an employee or representative of Farids or EA authorized to make such statement or announcement on behalf of Farids or EA, as applicable.",
            "target": "No",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 234
        },
        {
            "input": "25,000 Restricted common shares of TDA, a. As of the date of this agreement, Company has sold stock at $2.50/share. b. Par Value is $.0001 per share.",
            "target": "No",
            "document_name": "HALITRON,INC_03_01_2005-EX-10.15-SPONSORSHIP AND DEVELOPMENT AGREEMENT.PDF",
            "index": 235
        },
        {
            "input": "In the event of a Vert-Non-Renewal Election, in addition to any rights or remedies that may be available to Converge under the Subscription License Agreement, the provisions of Section 8 above shall cease to apply with respect to Converge's solicitation or encouragement of any of the VNE Service Personnel to terminate their employment or independent contracting relationship with VNE and become an employee or independent contractor of Converge or its Affiliate.",
            "target": "No",
            "document_name": "VERTICALNETINC_04_01_2002-EX-10.19-MAINTENANCE AND SUPPORT AGREEMENT.PDF",
            "index": 236
        },
        {
            "input": "The Sponsor acknowledges that Racing has arranged and may arrange in the future for other sponsors for the Racing Team. Racing agrees that, during the term of this Agreement, (i) Sponsor shall have the right to approve or disapprove any additional sponsor identified by Racing, and (ii) unless another proposed sponsor has agreed to pay a sponsorship fee that exceeds the amount paid by Sponsor, no other sponsor shall receive any benefit of greater value (including either an equivalent or a more prominent use of another sponsor's name, logo or other identifying information) than the Benefits provided to the Sponsor hereunder.",
            "target": "No",
            "document_name": "GAINSCOINC_01_21_2010-EX-10.41-SPONSORSHIP AGREEMENT.PDF",
            "index": 237
        },
        {
            "input": "This Agreement shall commence as of the Effective Date and shall continue unless and until terminated as provided herein.",
            "target": "No",
            "document_name": "Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF",
            "index": 238
        },
        {
            "input": "Commercial General Liability: [***] dollars ($[***]) per occurrence; [***] dollars ($[***]) Product and Completed Operations aggregate, including Premises & Operations, Personal Injury, Product and Completed Operations; [***] dollars ($[***]) combined single limit on all owned, non-owned and hired vehicles of such Party.",
            "target": "No",
            "document_name": "PhasebioPharmaceuticalsInc_20200330_10-K_EX-10.21_12086810_EX-10.21_Development Agreement.pdf",
            "index": 239
        },
        {
            "input": "Such license shall be transferrable subject to the foregoing restriction with any sale or transfer of a SpinCo business that utilizes such Intellectual Property, but, for the avoidance of doubt, such license shall not otherwise be sublicensable or transferable",
            "target": "No",
            "document_name": "INGEVITYCORP_05_16_2016-EX-10.5-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 240
        },
        {
            "input": "Roche shall have the right to extend the term of the CDx Development Program, upon [\u2026***\u2026] prior written notice to FMI as specified in Section 19.13, for additional three (3) year periods, during any period of time in which Roche is a majority shareholder of FMI.",
            "target": "No",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 241
        },
        {
            "input": "The construction, interpretation, and performance of this Agreement and all transactions under it shall be governed by the laws of the State of Texas, irrespective of its conflict of law principles.",
            "target": "No",
            "document_name": "FTENETWORKS,INC_02_18_2016-EX-99.4-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 242
        },
        {
            "input": "Such certificate will provide that there shall be no cancellation, non-renewal, or modification of such coverage without thirty days' prior written notice to the Company.",
            "target": "No",
            "document_name": "UAGHINC_04_14_2004-EX-10.18-MAINTENANCE AGREEMENT.PDF",
            "index": 243
        },
        {
            "input": "Agent shall have the exclusive right to use the Stores and all other Assets for the purpose of conducting the GOB Sale, free of any interference from any entity or person, subject to compliance with the Sale Guidelines (as defined below) and Approval Order;",
            "target": "No",
            "document_name": "BONTONSTORESINC_04_20_2018-EX-99.3-AGENCY AGREEMENT.PDF",
            "index": 244
        },
        {
            "input": "The Owner Indemnified Parties' additional insured status will not limit the application of insurance protection as required by this Agreement which arises out of the Operator's indemnity obligations. These policies shall provide primary coverage for claims in which Operator has agreed to hold harmless and/or to indemnify the Owner Indemnified Parties.",
            "target": "No",
            "document_name": "VERTEXENERGYINC_08_14_2014-EX-10.24-OPERATION AND MAINTENANCE AGREEMENT.PDF",
            "index": 245
        },
        {
            "input": "Notwithstanding Article 9.3., [CERES/IGER] will have the right to terminate this Agreement including the Program at any time with [three (3)] months' prior written notice.",
            "target": "No",
            "document_name": "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.PDF",
            "index": 246
        },
        {
            "input": "Upon termination, ENVISION shall have eighteen (18) months to exhaust any inventories, packaging and advertising materials bearing the \"SierraSil\" trademark and SIERRA shall have first option to buy back any inventory at ENVISION's net purchase price.",
            "target": "No",
            "document_name": "LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT.PDF",
            "index": 247
        },
        {
            "input": "Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an \"Apparent Defect\"), such notification to be provided within thirty (30) Working Days of receipt of the Product at Kitov's warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved.",
            "target": "No",
            "document_name": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement.pdf",
            "index": 248
        },
        {
            "input": "During the Promotion Period, iVillage traffic shall be audited by a third party traffic auditor listed on Exhibit A and iVillage shall provide FMM with relevant reports on a biweekly basis.",
            "target": "No",
            "document_name": "IVILLAGEINC_03_17_1999-EX-10.16-SPONSORSHIP AGREEMENT.PDF",
            "index": 249
        },
        {
            "input": "Zanotti hereby agrees that Aura may, at any given time, store up to two (2) AuraGen systems in such Zanotti facilities as Aura may designate from time to time.",
            "target": "No",
            "document_name": "AURASYSTEMSINC_06_16_2010-EX-10.25-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 250
        },
        {
            "input": "Notification to Miltenyi by Bellicum must occur within [...***...] days after Bellicum or Bellicum's designated recipient of the shipment becomes aware or reasonably should have become aware that the Miltenyi Product fails to comply with the Miltenyi Product Warranty.",
            "target": "No",
            "document_name": "BELLICUMPHARMACEUTICALS,INC_05_07_2019-EX-10.1-Supply Agreement.PDF",
            "index": 251
        },
        {
            "input": "Distributor acknowledges that Company owns and retains all patents, trademarks, copyrights and other proprietary rights in the Products, and agrees that it will not at any time during or after the termination of this Agreement assert or claim any interest in or take any action which may adversely affect the validity or enforceability of any trademark, trade name, trade secret, copyright, or other proprietary right owned by or licensed to Company.",
            "target": "No",
            "document_name": "StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement.pdf",
            "index": 252
        },
        {
            "input": "In case that the Driver User unilaterally terminates the Financial Leasing Agreement in advance, Party B shall collect the liquidated damages from the Driver User within 30% of the \"down payment + total monthly rent + last payment\" stipulated in the Financial Leasing Agreement;",
            "target": "No",
            "document_name": "SENMIAOTECHNOLOGYLTD_02_19_2019-EX-10.5-Collaboration Agreement.PDF",
            "index": 253
        },
        {
            "input": "For each Default Month, the Party in default shall pay a penalty equal to five (5) times the Party not in default's corporate average yield during the Default Month for each shipment below the performance commitment",
            "target": "No",
            "document_name": "DYNAMEXINC_06_06_1996-EX-10.4-TRANSPORTATION SERVICES AGREEMENT.PDF",
            "index": 254
        },
        {
            "input": "In the event that Company does not timely delivery a ROFR Purchase Notice, the Farids Group may sell the ROFR Shares to the proposed transferee identified in the ROFR Sale Notice at the ROFR Sale Price and on the other terms and conditions set forth in the ROFR Sale Documentation no later than three (3) business days following the date the Farids Group proposed to effect such Transfer in the ROFR Sale Notice (the \"ROFR Transfer Period\").",
            "target": "No",
            "document_name": "ROCKYMOUNTAINCHOCOLATEFACTORY,INC_12_23_2019-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.PDF",
            "index": 255
        },
        {
            "input": "If you have transferred your Interests in violation of this Agreement you shall be considered in breach of this Agreement.",
            "target": "No",
            "document_name": "JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.PDF",
            "index": 256
        },
        {
            "input": "The parties agree that Client will not be charged a higher fee than what is being made available by EFS to its other Clients for similar services.",
            "target": "No",
            "document_name": "PlayboyEnterprisesInc_20090220_10-QA_EX-10.2_4091580_EX-10.2_Content License Agreement_ Marketing Agreement_ Sales-Purchase Agreement1.pdf",
            "index": 257
        },
        {
            "input": "HealthGate agrees that at the time of termination of this Agreement, it will render all assistance, provide all documentation and undertake all actions to the extent necessary to effect an orderly assumption of the Services by the Publishers or, at the Publishers' option, by a replacement contractor;",
            "target": "No",
            "document_name": "HEALTHGATEDATACORP_11_24_1999-EX-10.1-HOSTING AND MANAGEMENT AGREEMENT (1).pdf",
            "index": 258
        },
        {
            "input": "Developer may not contest the validity of, by act or omission jeopardize, or take any action inconsistent with, DSS's ownership rights or goodwill in the Technology or Improvements, including any attempted registration of the Technology or Improvements in Hong Kong or in any other legal jurisdiction, or any attempts to license the same to any unauthorized third Person.",
            "target": "No",
            "document_name": "HfEnterprisesInc_20191223_S-1_EX-10.22_11931299_EX-10.22_Development Agreement.pdf",
            "index": 259
        },
        {
            "input": "Subject to the terms and conditions of this Agreement, WGT grants to Distributor a nontransferable license to do the following in the Territory during the Term: (a) market and distribute the Product to resellers; (b) demonstrate the Product to potential resellers; (c) use the Product internally for the sole purpose of providing this product support specified in paragraph 4.1(c); (d) use and display the Trademarks in connection with marketing and distributing the Product in the Territory pursuant to paragraphs (a) and (b) above.",
            "target": "No",
            "document_name": "EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT.PDF",
            "index": 260
        },
        {
            "input": "Within thirty (30) calendar days of the arrival of each lot of API at the manufacturing facility designated by INTERSECT, INTERSECT shall inspect and test each lot of API at its own cost and expense.",
            "target": "No",
            "document_name": "INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT.PDF",
            "index": 261
        },
        {
            "input": "Vendor agrees that, without the prior written consent of the Distributor, for a period beginning from the date of this Agreement and ending three (3) years after the termination of this Agreement, neither Vendor nor any of its affiliates or representatives will: (1) employ or solicit to employ any of the employees of Distributor; or (2) encourage of the employees of the Distributor or its subsidiaries to leave the employment of Distributor; provided, however, this Section shall not apply to any such employee who has been terminated by or left the employment of Distributor prior to the Effective Date or, if employed by Distributor as of the Effective Date, any employee who has not been employed by Distributor for at least one (1) year after the end of such employment.",
            "target": "No",
            "document_name": "ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT.PDF",
            "index": 262
        },
        {
            "input": "No party may transfer or assign its rights or obligations under this Agreement without the prior written consent of the other parties and any transfer or assignment or purported transfer or assignment in contravention of this Section 18 shall be void and without force or effect.",
            "target": "No",
            "document_name": "OLDAPIWIND-DOWNLTD_01_08_2016-EX-1.3-AGENCY AGREEMENT1.pdf",
            "index": 263
        },
        {
            "input": "COMPANY will pay JHU a fee equal one percent (1%) of the Aggregate Consideration received by the COMPANY, or the total amount received by stockholders of COMPANY, upon the occurrence of a Liquidity Event.",
            "target": "No",
            "document_name": "VirtuosoSurgicalInc_20191227_1-A_EX1A-6 MAT CTRCT_11933379_EX1A-6 MAT CTRCT_License Agreement.pdf",
            "index": 264
        },
        {
            "input": "Worker's Compensation Insurance which shall fully comply with the statutory requirements of all applicable state and federal laws.",
            "target": "No",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 265
        },
        {
            "input": "This Agreement shall commence on the Effective Date and, shall continue for the duration of the Lease, unless terminated earlier pursuant to Section 3.2 or 3.3.",
            "target": "No",
            "document_name": "VERTEXENERGYINC_08_14_2014-EX-10.24-OPERATION AND MAINTENANCE AGREEMENT.PDF",
            "index": 266
        },
        {
            "input": "Bonds and Insurance: the Transporter and the interested Senders in the Sole Risk Proposal shall obtain the necessary bonds and insurance to cover any Risk derived from the Sole Risk Proposal under terms reasonably acceptable for the Transporter, without prejudice of obtaining all other bonds and insurance requested by the Transporter.",
            "target": "No",
            "document_name": "GRANTIERRAENERGYINC_05_07_2012-EX-10.6-TRANSPORTATION CONTRACT.PDF",
            "index": 267
        },
        {
            "input": "You may not permit the Franchised Business to be operated, managed, directed, or controlled by any other person without our prior written consent.",
            "target": "No",
            "document_name": "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.pdf",
            "index": 268
        },
        {
            "input": "SERVICERS may terminate this Agreement prior to its expiration for cause upon prior written notice to ISO as follows:<omitted>(g) Upon an assignment of this Agreement by ISO without SERVICERS' prior written consent;",
            "target": "No",
            "document_name": "IPAYMENT,INC_05_14_2007-EX-10.1-SPONSORSHIP AGREEMENT.PDF",
            "index": 269
        },
        {
            "input": "Integrity will hold exclusive worldwide rights to promote and sell the product to/through the following distribution channels: Christian retail (CBA or Christian Booksellers Association markets), direct mail (including continuity sales, church sales, digital and e-commerce sales.)",
            "target": "No",
            "document_name": "IntegrityMediaInc_20010329_10-K405_EX-10.17_2373875_EX-10.17_Co-Branding Agreement.pdf",
            "index": 270
        },
        {
            "input": "Such policy shall provide, in addition to other protection, protection against any and all claims, demands, and causes of action arising out of any act, omission, negligence or otherwise giving rise to a third party claim.",
            "target": "No",
            "document_name": "HERTZGLOBALHOLDINGS,INC_07_07_2016-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 271
        },
        {
            "input": "During the term of this Agreement, Consultant will not, directly or indirectly (whether for compensation or without compensation) engage in or provide consulting services, or enter into any agreement either written or oral, that would present a material conflict with any of the provisions of this Agreement, or would preclude Consultant from complying with the terms and conditions hereof.",
            "target": "No",
            "document_name": "ADUROBIOTECH,INC_06_02_2020-EX-10.7-CONSULTING AGREEMENT(1).PDF",
            "index": 272
        },
        {
            "input": "If THI does not make the obligatory payments as stated in 3(a) by the dates stated, the Exclusive License will revert back to Premier, provided, however, that in such event, THI would still be entitled to a proportionate interest in any Covid-19 Licensed Products, such portion being equal to a fraction, the numerator of which shall be the actual amount paid and the denominator of which shall be $2,000,000.",
            "target": "No",
            "document_name": "PREMIERBIOMEDICALINC_05_14_2020-EX-10.2-INTELLECTUAL PROPERTY AGREEMENT.PDF",
            "index": 273
        },
        {
            "input": "Company's audit: at any time during the Term, the Repairer may: (i) audit the management and the performance of the Company's maintenance activities which are still under Company'sresponsibility; and/or, (ii) arrange for operational visits, in order to check that the Company complies with its obligations under this Agreement; and/or, (iii) investigate in any place, with the assistance of the Company, the causes of any abnormal removal or failure rate of any Itemand/or Abnormal Use.",
            "target": "No",
            "document_name": "AzulSa_20170303_F-1A_EX-10.3_9943903_EX-10.3_Maintenance Agreement1.pdf",
            "index": 274
        },
        {
            "input": "Subject to the condition above, HEMISPHERX hereby grants SCIEN the exclusive license to sell, market, and distribute Product for use in the Field in the Territory for Direct Access/EAP and Regulatory Agency-Approved (RAA) purposes.",
            "target": "No",
            "document_name": "HEMISPHERX - Sales, Marketing, Distribution, and Supply Agreement.PDF",
            "index": 275
        },
        {
            "input": "NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR ANY LOST PROFITS, OR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS SECTION 11.4 IS INTENDED TO OR SHALL LIMIT OR RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER SECTION 11.1 or 11.2, OR DAMAGES AVAILABLE FOR A PARTY'S BREACH OF CONFIDENTIALITY OBLIGATIONS UNDER ARTICLE 12.",
            "target": "No",
            "document_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
            "index": 276
        },
        {
            "input": "M&I has entered into a Master Preferred Escrow Agreement (\"Escrow Agreement\") with Data Securities International, Inc. (\"DSI\"), Account no. 1309046-0001, pursuant to which M&I has deposited with DSI the source code for the IBS Licensed Software (the \"IBS Software\").",
            "target": "No",
            "document_name": "TRICITYBANKSHARESCORP_05_15_1998-EX-10-OUTSOURCING AGREEMENT.PDF",
            "index": 277
        },
        {
            "input": "Such records will be open for inspection at the principal place of business of each party (the \"Inspected Party\") during such [ * ] period by an independent auditor chosen by the other party (the \"Inspecting Party\") and reasonably acceptable to the Inspected Party for the purpose of verifying the amounts payable by Astellas to FG hereunder or the accuracy of the [ * ] Percentage and/or Fully Burdened Costs.",
            "target": "No",
            "document_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATION AGREEMENT.PDF",
            "index": 278
        },
        {
            "input": "Minimum response time for R2 detect delay + generate detect delay + generate delay compelled signaling delay detect delay + decision detect delay + decision delay + delay + generate delay - -------------------------------------------------------------------------------------------- ------------ Accept Levels -5 dBm0 to -31.5 dBm0 must Minimum power is detect; configurable from -25 dBm to -38.5 dBm0 must reject -45 dBm per frequency",
            "target": "No",
            "document_name": "SUMMAFOURINC_06_19_1998-EX-10.3-SOFTWARE LICENSE AND MAINTENANCE AGREEMENT.PDF",
            "index": 279
        },
        {
            "input": "If FMI is unable or unwilling to develop and commercialize an Immuno Clinical Study assay or CDx assay resulting from the Immunotherapy Testing Platform Development Program in a given country within the Territory as specified in an R&D Plan for any reason other than a breach of this Agreement by Roche, and on the timeline agreed to in such R&D Plan, then, effective on the end of the timeline specified in such R&D Plan, FMI hereby grants to Roche a non-exclusive, royalty-free, perpetual, and sublicensable license under any intellectual property invented by FMI arising from the Immunotherapy Testing Platform Program or the Immunotherapy Testing Platform Development that is necessary for Roche to develop and commercialize such tests in such country in the Territory.",
            "target": "Yes",
            "document_name": "FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement.PDF",
            "index": 280
        },
        {
            "input": "Supplier hereby grants Bank of America a nonexclusive, worldwide, irrevocable, perpetual license to: (a) any patents related to or necessary or desirable to use the Software to the extent such patents are now held, licensed to or hereafter acquired by Supplier, for the purpose of allowing Bank of America and its Affiliates and permitted assigns to install, copy, use, execute, modify, distribute (as necessary or useful for Bank of America and its Affiliates and permitted assigns to enjoy their rights as set forth in the Agreement), make, have made, enhance, improve and alter the Software (both in Object Code and Source Code form) as necessary to conduct Bank of America business in accordance with the terms and restrictions or this Section; (b) any Copyrights now held, licensed to or hereafter acquired by Supplier in the Software for the purpose of allowing Bank of America and its Affiliates an permitted assigns to install, copy, use, execute, modify, distribute (as necessary or useful for Bank of America and its Affiliates and permitted assigns to enjoy their fights as set forth In the Agreement, produce derivative works from and<omitted>display such Software (both in Object Code and Source Code for ); any (c) other Intellectual Property Rights or Supplier in the Software as are necessary or useful for Bank of America, its Affiliates and permitted assigns to install, copy, use, execute, modify, distribute, enhance, improve and alter and copy the Software (both in Object Code and Source Code form) for the purpose of conducting Bank of America business in accordance with the terms and restrictions of this Section.",
            "target": "Yes",
            "document_name": "CardlyticsInc_20180112_S-1_EX-10.16_11002987_EX-10.16_Maintenance Agreement1.pdf",
            "index": 281
        },
        {
            "input": "RemainCo shall have, and SpinCo hereby grants to RemainCo, an unlimited, non-exclusive, perpetual, irrevocable, royalty free, worldwide right and license to use the content contained in the Steam Book, including the current edition and any past edition and any future edition to which RemainCo makes a contribution, for any purpose, including, without limitation, to reproduce, publicly display, modify, make derivative works, distribute, publicly perform and distribute for RemainCo's internal business purposes, including in connection with customer related activities, provided, however, that RemainCo shall (i) not use any non-nuclear content contained in the Steam Book in connection with publishing or distributing a publication which competes with the Steam Book and (ii) provide attribution and accreditation using a copyright notice having the format required by law in connection with the use of any protectable expression of the non-nuclear content contained in the Steam Book",
            "target": "Yes",
            "document_name": "BABCOCK_WILCOXENTERPRISES,INC_08_04_2015-EX-10.17-INTELLECTUAL PROPERTY AGREEMENT between THE BABCOCK _ WILCOX COMPANY and BABCOCK _ WILCOX ENTERPRISES, INC..PDF",
            "index": 282
        },
        {
            "input": "Said examination shall be at WLI's sole cost and expense during normal business hours and upon reasonable notice, and may not be conducted more than once annually; provided, however, -------- ------- that if such audit reveals an underpayment by Power2Ship of more than 10% for the period audited, Power2Ship shall pay WLI's actual costs and expenses for performing such audit.",
            "target": "No",
            "document_name": "VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT.PDF",
            "index": 283
        },
        {
            "input": "Airspan shall not be liable to Distributor on account of termination or expiration of this Agreement for reimbursement or damages for loss of goodwill, prospective profits, or anticipated orders, or on account of any expenditures, investments, leases, or commitments made by either party, or for any other reason whatsoever based upon or growing out of such termination or expiration.",
            "target": "No",
            "document_name": "AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement.PDF",
            "index": 284
        },
        {
            "input": "For the avoidance of doubt, it is recorded that SAP AFRICA will not be liable under this AGREEMENT for: 11. 3. 1 the MODIFICATION or improvement of the SOFTWARE by TELKOM to fit the particular requirements of TELKOM; or 11. 3. 2 the correction of any data errors resulting from MODIFICATIONS or EXTENSIONS by TELKOM or its agents; or 11. 3. 3 the correction of any data errors as a result of misuse of the SOFTWARE by TELKOM or its agents; or 11. 3. 4 preparation or conversion of data by TELKOM into the form required for use with the SOFTWARE.",
            "target": "No",
            "document_name": "TELKOMSALTD_01_30_2003-EX-10-LICENCE AND MAINTENANCE AGREEMENT.PDF",
            "index": 285
        }
    ]
}